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Abstract
Pulsatile blood flow consists of two components: steady flow and oscillatory flow.
Steady blood flow is primarily regulated by vascular resistance while vascular
compliance represents a key mediator of oscillatory blood flow. However, most studies
investigating the regulation of cerebral blood flow in humans have focused on vascular
resistance. Recently, emerging evidence has implicated vascular compliance as an
important contributor to the regulation of cerebral perfusion. Therefore, the research
contained herein aimed to i) quantify cerebrovascular compliance responses to blood
pressure alterations and ii) explore mechanisms regulating cerebrovascular compliance in
humans. The studies employed a Windkessel modelling approach to calculate
cerebrovascular compliance using blood pressure waveforms measured at the brachial
artery and middle cerebral artery blood velocity waveforms. Study One evaluated the
nature of the cerebrovascular compliance response to transient reductions in blood
pressure induced by standing upright. The findings demonstrate rapid and large increases
in cerebrovascular compliance that contribute to the preservation of systolic blood
velocity during the hypotensive phase of standing. Study Two investigated the impact of
cerebral vasodilation on cerebrovascular compliance. Two vasodilatory stimuli,
hypercapnia acting primarily through endothelial pathways and sodium nitroglycerin
acting through non-endothelial pathways, produced reductions in cerebrovascular
compliance. Hypercapnia dilates the entire cerebral vascular bed while sodium
nitroglycerin dilates only the large cerebral arteries. Nonetheless, similar reductions in
cerebrovascular compliance were observed. Study Three examined the role of
sympathetic innervation, cholinergic innervation, and myogenic mechanisms in
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regulating cerebrovascular compliance. Distinct blockade of 𝛼-adrenergic receptors
(phentolamine), endothelial muscarinic receptors (glycopyrrolate), and calcium channels
(nicardipine), produced large increases in cerebrovascular compliance. Similar changes in
cerebrovascular compliance were observed under baseline conditions and during
oscillatory lower body negative pressure to induce blood pressure fluctuations. Overall,
these studies provide support for the role of cerebrovascular compliance in regulating
cerebral perfusion. Additionally, these studies generated new knowledge regarding
neural, endothelial, and myogenic mechanisms governing human cerebrovascular
compliance.
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Summary for Lay Audience
In humans, the brain is an important organ that allows us to think, speak, move, and
survive. For our brain to function properly it needs blood to deliver key nutrients such as
oxygen and glucose which allow the brain to communicate signals to different areas
within the brain and to the rest of the body. The amount of blood flow to the brain is
controlled by the arteries. For example, the arteries can change size by dilating
(becoming larger) or constricting (becoming smaller) to allow more flow or less flow.
Another way the arteries can control blood flow is by changing how elastic the arteries
are. When arteries are elastic, meaning they can be stretched, they will be able to expand
with an increase in pressure and allow more blood volume to be stored in the arteries
during systole. This dissertation studies the role that elastic arteries play in regulating
blood flow in the brain under conditions like standing upright. Also, the studies examine
the different factors that can change how elastic the arteries are. This dissertation has
provided new knowledge on the elastic behaviour of the arteries in the brain. When
standing upright, the arteries increase how elastic they are to help maintain adequate
blood flow to the brain. Also, this dissertation shows that numerous factors can change
how elastic the arteries in the brain are such as dilating or constricting the arteries.
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Chapter 1

1

Introduction

The brain represents one of the most highly perfused organs with tight regulation of
cerebral blood flow to support optimal functioning and human survival. The brain
requires a high percentage of resting blood flow due to its high metabolic demands paired
with its limited capacity for storage of oxygen and glucose. As such, disruptions to
cerebral blood flow can lead to cerebral ischemia and subsequently impaired neural
function (87), or hyperperfusion which if sustained risks damage to the microvasculature
(100). Therefore, intricate and redundant regulatory mechanisms are critical for the
maintenance of cerebral perfusion and delivery of nutrients, particularly oxygen and
glucose.
Historically, studies of cerebrovascular regulation in humans have focused on changes in
vascular resistance. Mediated by alterations in vessel diameter, vascular resistance affects
the steady component of blood flow, that is, the forward moving flow in a vascular bed
(201). However, blood flow in the human cardiovascular system additionally includes an
oscillatory component that is largely influenced by vascular compliance. Vascular
compliance, namely the elasticity of blood vessels, influences the distension and recoiling
action of the vasculature (201). More precisely, vessel distension during systole absorbs
pressure and temporarily stores blood volume while vessel recoil during diastole propels
blood forward. As such, vascular compliance contributes importantly to oscillatory flow
across a cardiac cycle and the regulation of blood flow in a vascular bed. Yet, compliance
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of the cerebral vascular bed remains understudied, largely due to access difficulties
imposed by the skull.
In the last two decades, application of imaging techniques as well as modelling
approaches have made the study of human cerebrovascular compliance possible. With
magnetic resonance imaging, arterial spin labelling approaches have determined
compliance of the cerebral vasculature through quantifying changes in arterial blood
volume and changes in brachial artery blood pressure between systole and diastole (i.e.,
change in volume for a given change in pressure) (187, 199). However, measures of
cerebrovascular compliance provided by imaging approaches are generally limited to
resting, supine conditions. Windkessel models are mathematical models incorporating
both vascular resistance and compliance features and can be applied to the cerebral
circulation with measures of blood pressure and cerebral blood velocity. As such,
Windkessel models permit the calculation of compliance during more dynamic
conditions. Previously, the contribution of vascular compliance to the cerebral pressureflow relationship was examined during dynamic alterations in blood pressure induced
through drug infusions (40), oscillatory lower body negative pressure (176), thigh-cuff
approaches (177), and sit-to-stand models (177). Both single resistance and Windkessel
models were employed to predict the cerebral blood velocity response from the measured
blood pressure profile (40, 176, 177). Regression-based modelling approaches
demonstrated a stronger fit between the measured middle cerebral artery velocity and the
Windkessel models compared with single-resistance models (40, 176, 177). These
findings demonstrate that vascular compliance contributes to the regulation of cerebral
perfusion, particularly during dynamic alterations in blood pressure.
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While these recent investigations highlight the importance of considering vascular
compliance in studies of cerebrovascular regulation, our knowledge of cerebrovascular
compliance remains in its infancy. In particular, the nature of the cerebrovascular
compliance response during blood pressure alterations has not yet been quantified. The
cerebral circulation demonstrates hysteresis whereby the vasculature is less effective in
regulating against hypotensive conditions (178). As such, cerebral blood flow responses
to transient hypotension are critical with impaired regulatory responses leading to
syncope (180). Understanding the vascular compliance response during transient
hypotension, including the magnitude and temporal nature of the response, is of particular
interest. Therefore, this forms the rationale for Study One of the present dissertation.
Evidence that vascular compliance plays a role in cerebral blood flow regulation also
highlights the need to understand mechanisms which modulate cerebrovascular
compliance. The mechanisms mediating alterations in cerebrovascular resistance have
been studied extensively in humans. Major effectors of vascular resistance in the cerebral
circulation include arterial blood gas concentrations (e.g., carbon dioxide), neural
innervation, myogenic reactivity, and endothelial mechanisms. However, whether these
factors also affect cerebrovascular compliance remains unknown. Therefore, this forms
the rationale for Study Two and Study Three of the present dissertation.
The overall objective of the present dissertation was to evaluate i) the cerebrovascular
compliance responses to transient blood pressure alterations in humans and ii) the various
mechanisms of control underlying adjustments to cerebrovascular compliance. The
research contained herein tested the overall hypothesis that cerebrovascular compliance
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contributes to the regulation of cerebral perfusion during blood pressure alterations and
that cerebrovascular compliance is modified by neural, myogenic, and endothelial inputs.
Study One. Rapid changes in vascular compliance contribute to cerebrovascular
adjustments during transient reductions in blood pressure in young, healthy adults.
Purpose: To quantify within-beat changes in cerebrovascular compliance and resistance
during transient reductions in blood pressure induced by a sit-to-stand model.
Hypothesis: Cerebrovascular processes induced by reductions in blood pressure involve
increases in cerebrovascular compliance contributing to the preservation of systolic blood
velocity.
Study Two. Vasodilation by carbon dioxide and sodium nitroglycerin reduces
compliance of the cerebral arteries in humans.
Purpose: To determine cerebrovascular compliance before and following the
administration of two cerebral vasodilatory stimuli that operate primarily through
endothelial pathways (hypercapnia) and non-endothelial pathways (sublingual sodium
nitroglycerin).
Hypothesis: Vasodilatory stimuli would decrease compliance of the MCA vascular bed.
Study Three. Regulatory mechanisms of cerebrovascular compliance in humans:
sympathetic, cholinergic, and myogenic inputs.
Purpose: To examine the distinct impact that blockade of a-adrenergic, endothelial
muscarinic, and vascular smooth muscle calcium channel mechanisms has on
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cerebrovascular compliance under baseline conditions and during 0.03 Hz oscillatory
lower body negative pressure to induce BP fluctuations.
Hypothesis: Sympathetic and myogenic blockades would increase cerebrovascular
compliance and cholinergic blockade would reduce cerebrovascular compliance.

1.1 Anatomy of the Cerebral Vasculature
The cerebral vascular bed is supplied by two large pairs of arteries: the left and right
vertebral arteries and the left and right internal carotid arteries. Branching off the
subclavian arteries, the vertebral arteries travel through the transverse foramen of the
cervical vertebrae entering the foramen at the level of C6 (173). Entering the skull
through the foramen magnum, the left and right vertebral arteries join to form the basilar
artery at the base of the cerebrum. The left and right internal carotid arteries branch off
the common carotid artery around the level of cervical vertebrae C3-C5 (162) and pass
through the carotid canal as they enter the skull.
The basilar artery and the internal carotid arteries are connected through an arterial
anastomosis at the base of the cerebrum. The ring-like structure is termed the circle of
Willis after Thomas Willis, who provided a detailed narrative of the structure in his 1664
book Cerebri Anatome (140, 184). The circle of Willis, as shown in Figure 1.1, is formed
by the left and right posterior cerebral arteries (branching off the basilar artery), the left
and right posterior communicating arteries (connecting the posterior cerebral arteries to
the internal carotid arteries), the left and right middle cerebral arteries (branching off the
internal carotid arteries), the left and right anterior cerebral arteries (branching off the
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internal carotid arteries), and the anterior communicating artery (connecting the anterior
cerebral arteries).

Figure 1.1. The Circle of Willis at the base of the brain. Images obtained from the 20th
edition of Anatomy of the Human Body by Henry Gray and revised by Warren H. Lewis,
published in 1918.
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While this arterial anastomosis represents a complete circle of Willis, anatomical
variations are present in healthy individuals (105, 121) with numerous studies identifying
anomalous circles to be more common than complete circles in adults (91, 94, 105, 121,
184). Typical variations include hypoplasia of vessels (underdevelopment of vessels or
smaller than normal vessel size), duplication of vessels (e.g., second anterior
communicating artery), or absent vessels (e.g., posterior communicating artery) (12, 94,
121). In healthy adults, blood flow through the circle of Willis remains preserved despite
the presence of anatomical variations (94). Anomalous circles can become problematic
when the main suppling arteries are occluded (e.g., internal carotid arteries) (83, 94, 105).
In the case of occlusion or even stenosis of the supplying arteries, the communicating
arteries provide collateral circulation (8, 83). In such cases, hypoplasia or absence of
these vessels are associated with a higher risk of stroke (83) and aneurysm (94).
Nevertheless, anomalous circles, even in the absence of occlusion or stenosis, are
associated with the development of cerebrovascular disease due to the hemodynamic
stress caused by the variations (94, 95).
In his early review of the arterial anastomoses, Thomas Willis highlighted the
compensatory function of the arterial anastomoses (184). Indeed, a complete circle
provides collateral flow and consequently maintains cerebral blood flow in cases of
stenosis or occlusion of the supplying arteries (8, 83, 94, 105, 184). However, collateral
flow does not appear to occur in healthy circles under physiological conditions (8, 184).
An alternative hypothesis states that the circle of Willis functions as a pressure absorber
to protect the downstream microcirculation from high pressure conditions thereby
preventing damage to the blood brain barrier (184). More precisely, the communicating
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arteries would act as an energy dissipation system (184). Because collateral flow does not
occur in normal physiological conditions, this hypothesis assumes the communicating
arteries allow pressure to dissipate from high pressure zones to low pressure zones
without significant blood flow (184). Asynchronous pressure pulse arrival at the circle of
Willis, stemming from anatomical differences in arterial branching off the aorta between
the left and right sides (8, 184), provides an environment where pressure dissipation can
occur across the communicating arteries (184). According to this hypothesis, absence of
or hypoplasia of the communicating vessels would increase the hemodynamic stress
within the arteries of the circle of Willis and increase the risk of aneurysm and stroke (83,
94).
The large cerebral arteries that form the circle of Willis, as well as their branches are
known as the pial vessels. The pial vessels run along the outside of the cortex in the
subarachnoid space and are surrounded by cerebrospinal fluid (68, 71, 88). The pial
vessels begin to dive into the cerebral cortex becoming the penetrating arterioles running
in the Virchow-Robin space (68, 88). Eventually, as the penetrating arterioles dive deeper
into the cortex and the Virchow-Robin space disappears, the vessels are termed the
parenchymal arterioles and are in contact with astrocytic end-feet (68, 88). The pial,
penetrating, and parenchymal vessels of the cerebral circulation demonstrate differences
in innervation (see Section 1.3.3 Neural Control) and in structure. The larger pial vessels
are composed of a layer of endothelial cells, an internal elastic lamina, multiple layers of
smooth muscle cells, and the adventitia (88). The perivascular nerves innervating the pial
vessels run along the adventitia-media border (88). As the pial arteries progress into the
penetrating arterioles, the number of smooth muscle cell layers are gradually reduced to a
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single layer in the distal penetrating arterioles (88). Further, the distal penetrating
arterioles are characterized by a less prominent internal elastic lamina (88). Finally, the
parenchymal arterioles in the cortex contain a single layer of smooth muscle cells and the
outer membrane of the vessels becomes fused with the astrocytic end-feet (88).
The studies included in the present dissertation focus on the middle cerebral artery and
the downstream vascular bed. The internal carotid arteries accommodate approximately
80% of flow into the brain (184). The middle cerebral arteries represent the largest
branch off the internal carotid arteries (151) and supply a large portion of the cerebral
cortex (183) perfusing approximately 70-80% of the brain. Indeed, a strong correlation
exists between changes in middle cerebral artery blood velocity and cerebral blood flow
in response to physiological stimuli (24).

1.2 Cerebral Blood Flow
The human brain weighs approximately 2% of total body weight. Despite the relatively
small size of the human brain, it accounts for roughly 15% of total cardiac output at rest.
The “hungry” brain requires a high percentage of cardiac output at rest due to its high
metabolic demands and limited capacity for storage. The brain accounts for 20% of
resting oxygen consumption and 25% of resting glucose utilization. However, the brain is
unable to store sufficient levels of oxygen and glucose and thereby relies on adequate
blood flow for the delivery of nutrients to meet metabolic demands and ensure proper
functioning.
Blood flow, determined by the pressure gradient and vascular resistance, can be described
by Ohm’s Law applied to the cardiovascular system:
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[1] 𝑄 =

∆"
#

where Q represents blood flow, DP represents the pressure gradient, and R represents
vascular resistance. Poiseuille’s equation describes the pressure gradient across a vascular
segment:

[2] ∆𝑃 =

$%&'
() !

where DP represents the pressure gradient across the vascular segment, µ represents the
viscosity of the blood, L represents the length of the vascular segment, Q represents blood
flow, and r represents the radius of the vessel. Taken together, we can determine vascular
resistance as:

[3] 𝑅 =

$%&
() !

Therefore, modifications in the blood pressure gradient and vascular resistance regulate
blood flow with vascular resistance predominantly governed by vessel radius (r).
Blood flow in the cerebral vascular bed is unique from peripheral vascular beds as the
cerebral circulation is enclosed within a rigid skull. This creates an environment where
the cerebral arteries are exposed to external sources of pressure or intracranial pressure.
Thus, in addition to the pressure gradient within the vascular segment, the pressure
gradient across the vascular wall, termed the transmural pressure gradient, must be
considered. Cerebral perfusion pressure can be described by the following equation:
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[4] 𝐶𝑃𝑃 = 𝑀𝐴𝑃 − 𝐼𝐶𝑃
where CPP represents cerebral perfusion pressure, MAP represents mean arterial
pressure, and ICP represents intracranial pressure.
Poiseuille’s Law describes steady flow in a rigid tube with a fully-developed laminar
flow profile (201). The human cardiovascular system is described by pulsatile flow in
elastic arteries. Unlike steady flow, in which the driving pressure remains constant, in
pulsatile flow the driving pressure becomes oscillatory in time (201). Yet, as pressure
rises flow increases and as pressure falls flow decreases. In conditions where the change
in pressure is slow, pressure and flow will change together similar to steady Poiseuille
flow (201). However, elastic “tubes” or arteries create a scenario where pressure changes
act locally, stretching the vessel, and subsequent recoil produces a wave motion whereby
pressure and flow do not change uniformly at all positions along the vessel (201).
Nonetheless, pulsatile Poiseuille flow provides a foundation for studying and
understanding blood flow in humans.

1.2.1

Methods of Measuring Cerebral Blood Flow

Due to access difficulties, we have relied on relatively non-invasive, indirect
measurements of cerebral blood flow in humans. Early techniques for measuring human
cerebral blood flow included the Kety-Schmidt method. In 1945, Kety and Schmidt (98)
first reported the use of an inert gas to quantify cerebral blood flow in humans. With
simultaneous arterial blood (femoral artery) and cerebral venous blood (internal jugular
vein) samples during the inhalation of a low concentration nitrous oxide gas, cerebral
blood flow could be estimated based on the notion that the rate at which venous gas
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concentrations become similar to arterial gas concentrations depends upon blood flow
through the organ (98). While Kety and Schmidt (98) noted good agreement between
direct measures of cerebral blood flow in monkeys and measures obtained using their
approach, the method does come with some drawbacks including a more invasive
procedure, poor temporal resolution, and the inability to provide regional measures of
flow. Over the years, while the Kety-Schmidt technique was adapted (67, 110, 141, 154),
a key advancement for the measurement of human cerebral blood flow came in 1982 with
the application of Transcranial Doppler ultrasound.

1.2.1.1

Transcranial Doppler Ultrasound

Doppler ultrasound was first used to record blood flow in extracranial vessels in 1965
(130). At this time, recordings of intracranial vessels were restricted to surgical
procedures (137, 138) as the skull prevented sound waves from insonating these vessels
non-invasively (2). In 1982, a major breakthrough occurred when Aaslid and colleagues
(2) discovered that ultrasound waves in the frequency of 1-2 MHz were able to penetrate
through the skull in thinner regions of the temporal bone; with this approach the first ever
non-invasive recordings of blood velocity in the anterior cerebral, middle cerebral, and
posterior cerebral arteries were documented (2).
Transcranial Doppler ultrasound represents a highly applicable measurement technique
due to its non-invasive and high temporal resolution features. Based on the Doppler effect
(148), the ultrasound probe emits sound waves, most often at a frequency of 2 MHz, that
penetrate the skull at thinner regions known as ultrasonic windows (2). The sound waves
will travel the predetermined depth to the artery being insonated and reflect off red blood
cells travelling through the vessel. Once the reflected sounds waves reach the ultrasound
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probe, the Doppler shift is calculated as the difference between the frequency of the
transmitted and reflected sound waves (159). Blood velocity is calculated as:

[5] 𝑣 =

*" , .*# , -/01

where fD represents the Doppler shift, C represents the velocity at which ultrasound waves
travel in biological tissues, ft represents the frequency of the transmitted sounds waves,
and q represents the angle of insonation (159). The angle of insonation (angle between
transmitted sounds waves and direction of blood flow) becomes important in accurately
predicting cerebral arterial blood velocity. In transcranial Doppler examinations,
investigators aim for an angle less than 30 degrees, minimizing error to less than 15% (2).
Four ultrasonic windows have been identified: the transtemporal, transorbital,
submandibular, and suboccipital windows (148, 194). Most commonly used for
insonation of the arteries comprising the circle of Willis, the transtemporal window is
located above the zygomatic arch (2) and has three distinct windows between the eye and
the ear: anterior, middle, and posterior windows (148, 194). The studies in the present
dissertation focus on the middle cerebral artery and the remaining discussion will pertain
to insonation of this artery. After its bifurcation from the internal carotid artery, the
middle cerebral artery runs laterally and slightly anteriorly (148, 194). Therefore, the
transtemporal window generally permits optimal insonation of the middle cerebral artery
and blood flow through the artery will travel towards the probe (148, 194). From the
transtemporal window, the ipsilateral middle cerebral artery can be insonated at a depth
of 40-65mm (M1 segment) (11). Blood velocity in the middle cerebral artery generally
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falls within the range of 30 to 80 cm/s (11) and is dependent on age and sex (11, 148,
171). Single or dual monitoring is possible with transcranial Doppler ultrasound, though
similar velocities have been observed in the left and right middle cerebral arteries (2).
Transcranial Doppler ultrasound is used widely for its convenience and continuous
monitoring capabilities. Despite high temporal resolution, the approach does have
limitations that should be acknowledged, including poor spatial resolution as it provides
an index of global rather than regional blood flow (148, 194). Further, successful exams
are not always possible with reports that 10-15% of individuals have inadequate
ultrasonic windows preventing the insonation of intracranial vessels (148). Lastly,
transcranial Doppler ultrasound does not permit the imaging of vessels and consequently
measures of cross-sectional area cannot be obtained. Therefore, transcranial Doppler
ultrasound provides blood velocity and not blood flow. A common assumption made with
transcranial Doppler ultrasound is that the diameter of the artery being insonated remains
constant. Under such conditions, blood velocity measured with transcranial Doppler
ultrasound would be proportional to cerebral blood flow. The validity of transcranial
Doppler ultrasound in providing an estimate of cerebral blood flow is questioned during
conditions when arterial diameter may change. Transcranial Doppler ultrasound
techniques may be combined with imaging approaches (e.g., blood oxygen level
dependent magnetic resonance imaging) which enable measures of vessel cross-sectional
area for the calculation of cerebral blood flow.

1.3 Cerebral Blood Flow Regulation
Regulation of cerebral blood flow is supported by complex, integrative mechanisms to
support optimal brain function and human survival. Given the human brain’s high
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metabolic demand and limited capacity for storage of oxygen and glucose, disruptions to
cerebral blood flow, and subsequently delivery of oxygen and other nutrients, can have
detrimental effects on neural tissue. Indeed, the ability of the vasculature to respond to
diverse stimuli is essential for protecting against insufficient blood supply and cerebral
ischemia which can lead to impaired neural function or loss thereof (87). Further,
mechanisms of vascular regulation also protect against unduly high blood flow which, if
sustained, risks damage to the microvasculature (100). Therefore, the human brain relies
heavily on the precise regulation of blood flow to maintain structural and functional
integrity (45).
The cerebral vasculature is tightly regulated by many factors including endothelialderived vasoactive factors, arterial blood gases, the autonomic nervous system, cerebral
perfusion pressure, and neurovascular coupling. These factors are discussed in detail
below.

1.3.1

Endothelial Regulation

The endothelium, located within the innermost layer of the blood vessel wall (tunica
intima), forms the blood brain barrier in the cerebral microvasculature (3, 4). The single
layer of endothelial cells produces and releases a number of vasoactive mediators that
influence the contractile state of vascular smooth muscle cells (60, 181). Indeed,
endothelial dysfunction is implicated in numerous pathological states including
hypertension (27, 142, 143), stroke (169, 197), and Alzheimer’s disease (113, 211). The
most recognized mediators produced and released by the endothelium include nitric oxide
and prostaglandins.
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1.3.1.1

Acetylcholine and Muscarinic Receptors

The endothelial cells contain muscarinic receptors (M3 and M5) that bind acetylcholine
released from parasympathetic nerves in the brain. Upon acetylcholine binding to
muscarinic receptors, increases in intracellular Ca2+ concentrations activate two key
enzymes: endothelial nitric oxide synthase and phospholipase (43). Intracellular Ca2+
concentrations can be augmented through additional pathways beyond binding of
acetylcholine to muscarinic receptors including receptor binding of bradykinin and ATP,
as well as through a shear stress stimulus on the endothelium (43). Unlike the systemic
circulation where acetylcholine must diffuse from the neuromuscular junction to
endothelial cells to produce vasodilation, the presence of cholinergic innervation of the
cerebral vasculature enables acetylcholine to rapidly dilate the cerebral arteries (50).

1.3.1.1.1

Cholinergic Blockade: Glycopyrrolate

To assess the impact of cholinergic innervation on the cerebral vasculature,
pharmacological interventions can block the action of acetylcholine on the vessels.
Glycopyrrolate inhibits acetylcholine binding to muscarinic receptor subtypes 1 to 5 (M1
to M5) (39). Therefore, muscarinic receptors located on endothelial cells (M3 and M5)
cannot bind acetylcholine and elicit vasodilation. Of note, glycopyrrolate does not cross
the blood-brain barrier (147) and central cholinergic effects will persist. Therefore,
cholinergic nerves may still release additional vasodilator mediators such as nitric oxide
synthase and vasoactive intestinal peptide (74).

1.3.1.2

Endothelial Nitric Oxide Synthase and Nitric Oxide

Increases in endothelial intracellular Ca2+ activate the enzyme endothelial nitric oxide
synthase (43). Endothelial nitric oxide synthase converts L-arginine and oxygen to nitric
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oxide and L-citrulline (43). Nitric oxide will diffuse to the vascular smooth muscle cells
in the tunica media and activate guanylate cyclase (43) producing a signaling cascade that
reduces intracellular Ca2+ and ultimately elicits relaxation of smooth muscle cells.
Endothelial sources of nitric oxide contribute to resting blood flow in human peripheral
conduit arteries as inhibition of nitric oxide synthase by NG-monomethyl-L-arginine
reduces forearm (158) and femoral artery blood flow (149). Early animal work observed
contribution of endothelial derived nitric oxide to resting cerebral blood flow in rats
showing reductions in cerebral artery diameter following NG-monomethyl-L-arginine
(58). Further, in this same study in rats, the effect of inhibiting endothelial nitric oxide
production was greatest in the large cerebral arteries relative to smaller arterioles (58).
The findings in rats have been extended to humans whereby inhibition of nitric oxide
synthase (NG-monomethyl-L-arginine) produced reductions in internal carotid artery
blood flow (193) as well as global cerebral blood flow (92).

1.3.1.2.1

Nitric Oxide Donors: Sodium Nitroglycerin

Nitric oxide donors elicit vasodilation mediated by the action of nitric oxide on the
vascular smooth muscle cells, independent of the endothelium. Sodium nitroglycerin
represents a common treatment for angina (204) as it is rapidly absorbed across the
mucous membrane when administered sublingually as a spray (0.4 to 0.5 mg per spray)
(101). Lingual or sublingual spray administration of nitroglycerin produces vasodilation
of large conduit arteries such as the brachial artery (53) and the superficial femoral (210).
In the brachial artery, dilation was shown to occur rapidly (~ 2 minutes) after lingual
spray of nitroglycerin (53). While conduit arteries dilate following nitroglycerin
administration, the downstream vasculature demonstrates a differential response. More
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precisely, studies in animals demonstrate dilation of large coronary arteries but no change
in smaller coronary arteriolar diameter following nitroglycerin (106, 124, 157). In
humans, superficial femoral artery dilation was accompanied by a reduction in superficial
femoral blood flow suggesting constriction of the peripheral arterioles (210). Similar
findings were observed in the cerebral circulation with middle cerebral artery dilation
following nitroglycerin (78, 155) but reductions in middle cerebral artery blood velocity
(51, 155, 192, 210), no change in cerebral blood flow (51, 155, 192), and an increase in
cerebrovascular resistance (210). The heterogenous vascular responses likely relate to the
conversion of nitroglycerin to its vasoactive metabolite in larger arteries but lack thereof
in the smaller arterioles (106, 124, 157). Nitroglycerin interacts with a sulfhydrylcontaining group, likely cysteine, to produce a nitrosothiol, such as S-nitroso-L-cysteine,
to activate guanylate cyclase (106, 157). Findings of similar dilation of larger and smaller
coronary arteries with exogenous L-cysteine supports the notion that nitroglycerin does
not convert to its vasoactive metabolite in smaller arterioles (106, 124, 157).

1.3.1.3

Cyclooxygenase and Prostaglandins

An increase in intracellular Ca2+ in endothelial cells also activates phospholipase (43).
Phospholipase produces arachidonic acid which is subsequently converted to
prostaglandin H2 by the enzyme cyclooxygenase (43). Prostaglandin E2 and prostacyclin
are both dilators that are derived from prostaglandin H2 (43). Prostaglandin E2 and
prostacyclin will bind to EP and IP receptors, respectively, on the vascular smooth
muscle cells activating adenylate cyclase and subsequent signaling cascades which lead
to reductions in intracellular Ca2+ and vasodilation (43).
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Animal research has documented that prostacyclin and prostaglandins dilate large conduit
arteries (e.g., femoral artery) with prostacyclin demonstrating a larger dilatory effect (35).
In humans, the infusion of aspirin to block cyclooxygenase reduced prostacyclin
production by ~80% and resting forearm blood flow was attenuated (54). In the cerebral
circulation, Markus and colleagues (125) observed reductions in middle cerebral artery
blood velocity at rest following the inhibition of cyclooxygenase by indomethacin
suggesting decreased cerebral blood flow. These findings were recently extended by
Kellawan and colleagues (97) who reported reductions in cerebrovascular conductance,
cross sectional area, diameter, blood velocity, and blood flow in the large cerebral arteries
following indomethacin.

1.3.2

Carbon Dioxide

Partial pressure of arterial carbon dioxide (PaCO2) represents one of the most robust
stimuli that the cerebral vasculature reacts to. Under conditions of increased PaCO2
(hypercapnia), the cerebral vessels dilate to increase cerebral blood flow and with
decreased PaCO2 (hypocapnia) arterial constriction occurs leading to reductions in
cerebral blood flow. Because the cerebral vasculature is highly sensitive to PaCO2, even
small changes of ~1mmHg are shown to elicit alterations in cerebral blood flow (30). For
each 1mmHg change in PaCO2 or partial pressure of end-tidal carbon dioxide (PETCO2), a
2-4% change in cerebral blood flow or blood velocity is observed (96, 195).
Vasoreactivity to PaCO2 occurs at all levels of the cerebral vascular bed including
supplying arteries (96, 195), large cerebral arteries of the circle of Willis (7, 46, 47, 183),
and smaller cerebral arterioles (128, 156). However, heterogenous responses have been
observed at different levels of the arterial tree. First, vasoreactivity of the intracranial
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arteries differs from that of the extracranial arteries. Willie and colleagues (195) reported
greater reactivity to hypocapnia in the right vertebral artery compared to the left middle
cerebral and right posterior cerebral arteries. Further, during long duration hypercapnia
(~15 minutes), greater reactivity, per mmHg change in PaCO2, was observed in neck
arteries (internal carotid artery and vertebral artery) than cerebral arteries (middle
cerebral artery and posterior cerebral artery) (195). During a shorter hypercapnia protocol
(~5 minutes), Coverdale and colleagues (47) observed greater sensitivity in the right
middle cerebral artery compared with the right internal carotid artery. Cross sectional
area of the right middle cerebral artery was increased after one minute of hypercapnia
while cross sectional area of the right internal carotid artery was not changed after five
minutes (47) but was reported to change with a longer hypercapnic protocol in the study
by Willie and colleagues (195). Notably, the study by Willie and colleagues (195)
quantified cerebrovascular reactivity with blood flow in the internal carotid and vertebral
arteries but blood velocity in the middle cerebral and posterior cerebral arteries.
Coverdale and colleagues (46) later reported that cerebrovascular reactivity calculated
with blood velocity underestimates responses relative to reactivity quantified using blood
flow which may explain the divergent results between the two studies. Second,
differential vasoreactivity is documented between vessels within the circle of Willis.
With transcranial doppler ultrasonography, lower reactivity was observed in the posterior
cerebral artery when compared to the middle cerebral artery during re-breathing (161,
175), hypercapnia (82), and breath-hold (31) protocols. However, when relative reactivity
was calculated, the difference between the two arteries was abolished (82, 161, 175).
Finally, differences in reactivity patterns have been observed between hypercapnic and
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hypocapnic stimuli. Coverdale and colleagues (46) observed a greater change in middle
cerebral artery cross sectional area during hypercapnia (0.11±0.07mm2/Torr) compared
with hypocapnia (0.04±0.03mm2/Torr). Similar findings were reported for the internal
carotid artery (195). In addition to smaller changes in middle cerebral artery cross
sectional area with hypocapnia, delayed constriction is observed (47). During
hypercapnia, an increase in middle cerebral artery cross sectional area was observed after
one minute, while with the hypocapnic protocol, middle cerebral artery cross sectional
area was not decreased until minute four (47). In addition to reduced reactivity, greater
variability in the responses to hypocapnia have been noted (46).
The mechanisms mediating alterations in vessel diameter are complex. Carbon dioxide
freely crosses the blood brain barrier where carbonic anhydrase converts carbon dioxide
(CO2) and water (H20) to hydrogen ion (H+) and bicarbonate (HCO3-) through the
following equation:
"#$%&'("
#')*+$#,-

[6] 𝐶𝑂! + 𝐻! 𝑂 ,⎯⎯⎯⎯⎯⎯. 𝐻! 𝐶𝑂. ↔ 𝐻 / + 𝐻𝐶𝑂.!
It has long been debated whether carbon dioxide itself mediates alterations in cerebral
arterial diameter or whether the changes relate to decreases in pH (increased H+) as
carbon dioxide crosses the blood brain barrier. In humans, hypercapnia elicited an
increase in the cerebral blood flow index with both an increase in PaCO2 and a decrease
in pH (108). Subsequently, when carbon dioxide concentrations were maintained at
hypercapnic levels but pH was returned to baseline levels, the cerebral blood flow index
remained elevated (108). Further, Harder and Madden (79) examined the effect of
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reductions in PaCO2 with maintained pH on isolated segments of the middle cerebral
artery of cats. With reductions in carbon dioxide, and unaltered pH, membrane
depolarization was observed, suggesting vessel constriction (79). Together, these findings
suggest a role of carbon dioxide independent of pH in mediating diameter alterations.
However, animal studies also demonstrate that extracellular pH (i.e., cerebrospinal fluid)
affects cerebral arterial diameter. In anesthetized cats with a cranial window, hypercapnic
and hypocapnic conditions had no effect on arteriolar diameter when cerebrospinal fluid
pH was maintained (104). Additionally, when carbon dioxide levels were maintained, and
cerebrospinal fluid pH was altered, significant changes in arteriolar diameter were
recorded (104). In agreement with this investigation, isolated rat arterioles exposed to
increases in extracellular pH demonstrated vasoconstriction while carbon dioxide levels
were unchanged (14). Therefore, these findings suggest that extracellular pH independent
of carbon dioxide mediates vasoreactivity to hypercapnic and hypocapnic conditions. The
discrepancy in the aforementioned studies may relate to a number of factors including in
vitro vs. in vivo studies, the level of PaCO2 and pH stimuli, duration of challenge,
species, and variations in arteries (200). Nonetheless, independent but concomitant
regulation of vasoreactivity by PaCO2 and extracellular pH may occur (200).
The endothelium appears to contribute to cerebral arterial reactivity to altered carbon
dioxide levels. Following injury to the endothelium in pig pial arteries (by light/dye),
attenuation of hypercapnia-induced arterial dilation was observed suggesting a role for a
healthy functioning endothelium in vasoreactivity to carbon dioxide (196). This finding
has been replicated in humans in which patients with endothelial dysfunction (diabetes
mellitus or hypertension) demonstrated reduced vasoreactivity to hyperventilation and
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hypercapnia relative to healthy controls (112). Both nitric oxide and prostaglandins are
implicated for their contribution to carbon dioxide mediated alterations to cerebral
arterial diameter. In the previous study with diabetes mellitus and hypertension patients,
sodium nitroprusside (i.e., a nitric oxide donor) infusion abolished the differences in
vasoreactivity between patients and controls (112). In cultured human cerebral
endothelial cells, nitric oxide concentrations were measured under normocapnic,
hypercapnic, and hypocapnic conditions (62). Nitric oxide concentrations were
augmented during hypercapnia and attenuated during hypocapnia (62). Further,
hypercapnia-mediated increases in nitric oxide concentrations were attenuated with a
nitric oxide synthase inhibitor (N-nitro-L-arginine) (62). Importantly, alterations in nitric
oxide concentrations by hyper- and hypocapnia in human endothelial cells was
independent of changes in extracellular pH (62). In rats, pial arteriolar dilation with
hypercapnia was attenuated by approximately 50% following a nitric oxide synthase
inhibitor (N-nitro-L-arginine) (198). The hypercapnic-induced dilation was further
diminished to approximately 15-20% of baseline dilation with the cyclooxygenase
inhibitor indomethacin (198). Therefore, Xu and colleagues (198) highlight a role for
both nitric oxide and prostaglandins in hypercapnic vasodilation in rats. Prostaglandin
production via cyclooxygenase plays a role in human responses to hypercapnia as well.
Vasoreactivity of the middle cerebral artery in humans was significantly reduced during
hypercapnia following oral administration of indomethacin (22). Further, indomethacin
was shown to attenuate alterations in cerebrovascular conductance during hypercapnia
(22). Therefore, an intact, healthy endothelium is important for carbon dioxide mediated
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alterations in cerebral arterial diameter. Endothelial-mediated production of nitric oxide
and prostaglandins play a role in hypercapnia-induced dilation.

1.3.3

Neural Control

The autonomic nervous system consists of two major branches: the sympathetic nervous
system and the parasympathetic nervous system. While blood vessels in the peripheral
vasculature are richly innervated by the sympathetic nervous system, the cerebral vessels
are innervated with both sympathetic and parasympathetic nerves. Autonomic innervation
of the cerebral vessels is classified into extrinsic and intrinsic innervation.
The pial vessels, located on the outside of the cerebral cortex (i.e., extracerebral vessels),
are innervated by three extrinsic sources including the superior cervical ganglia, the
sphenopalatine and otic ganglia, and the trigeminal ganglia (74). First, sympathetic
nerves projecting from the superior cervical ganglia (located at the level of the cervical
vertebrae C1-C4) release the neurotransmitters norepinephrine and neuropeptide Y (74).
Animal data demonstrate that a-1 adrenergic receptors are the most common (adrenergic)
receptor observed in the cerebral circulation and are expressed with a high density in the
large intracranial arteries but a progressive decrease in density occurs as you travel down
the vascular bed with low expression in the parenchymal arterioles (29). Upon
norepinephrine binding to a-1 adrenergic receptors, signaling pathways become activated
eliciting vasoconstriction. Similarly, neuropeptide Y binds to Y1 receptors producing
vasoconstriction. The Y1 receptors are the primary NPY receptor in human cerebral
arteries and are observed in large cerebral arteries as well as parenchymal arterioles (5).
Second, the sphenopalatine ganglia (located in the pterygopalatine fossa) and otic ganglia
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(located below the foramen ovale) give rise to parasympathetic nerves releasing
acetylcholine, nitric oxide synthase, and vasoactive intestinal peptide (74). Acetylcholine
elicits vasodilation through binding muscarinic M5 receptors (74) located in the tunica
media and endothelium of cerebral arteries (170) while nitric oxide synthase yields the
potent dilator nitric oxide which activates guanylate cyclase in the smooth muscle cells to
produce vasodilation. Third, the trigeminal ganglia (located in the trigeminal cavity)
yields sensory nerves (74). This unique sensory innervation appears to act as a protective
mechanism, dilating the cerebral vessels following a constrictor stimuli (74). From their
origin (superior cervical ganglia, sphenopalatine ganglia, otic ganglia, trigeminal ganglia)
the nerves terminate in the adventitia-media border of both the pial vessels (88) and
penetrating arterioles, with the latter expressing decreased innervation density (41).
The parenchymal arterioles receive intrinsic innervation from neurons located within the
cortex (74). A key component of intrinsic innervation of the cerebral arterioles, the
neurovascular unit, is made up neurons, astrocytes, and blood vessels (68, 87). The
parenchymal arterioles are surrounded by, and in direct contact with, astrocytic end-feet
(68, 87, 88) and the neurons innervate both the arterioles and astrocytes (74). The close
anatomical relationship between these structures supports a functional coupling that is
vital to protect against cerebral ischemia (87). Three neural pathways intrinsically
innervate the parenchymal vessels originating from the nucleus basalis, locus coeruleus,
and the raphe nucleus (74). First, the nucleus basalis is located in the basal forebrain and
neurons arising from the nucleus basalis release acetylcholine and nitric oxide synthase
both involved in dilating the vessels (74). Second, the locus coeruleus, located in the
pons, projects neurons releasing norepinephrine (74). In the parenchymal arterioles, there
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is a shift from a-1 adrenergic receptors to a greater density of b-adrenergic receptors
(29). Upon norepinephrine binding to b-adrenergic receptors, the signaling pathway
activated elicits vasodilation. However, the neurons projecting from the locus coeruleus
largely target astrocytes where norepinephrine produces increased calcium concentrations
in the astrocyte end feet which elicits constriction of the parenchymal arterioles (132).
Finally, the raphe nucleus is located in the brainstem and neurons arising from the raphe
nucleus release serotonin (74). As a result, the neurons projecting from the raphe nucleus
may cause dilation or constriction of the parenchymal arterioles dependent on the area of
stimulation within the brainstem (74).
The role of sympathetic innervation in resting cerebral blood flow remains highly debated
(29). Early animal studies provide support for sympathetic innervation regulating cerebral
blood flow under resting conditions. In baboons, stimulation of the cervical sympathetic
trunk or intracarotid infusion of norepinephrine reduced cerebral blood flow (80) and in
goats, removal of the superior cervical ganglia increased cerebral blood flow (9). In
contrast, human investigations have reported varying results. A pharmacological
intervention to block norepinephrine from binding to a-adrenergic receptors
(phentolamine) did not alter resting cerebral blood flow in healthy adults with intact
cerebral autoregulation (160). In contrast, following a T2 sympathectomy procedure,
patients with palmar hyperhidrosis demonstrated vasodilation and increased blood flow
volume in the left internal carotid artery as well as augmented systolic blood velocity in
the left middle cerebral artery suggesting increased cerebral blood flow (90). Further, a
recent investigation observed elevated cerebral blood flow in patients with pure
autonomic failure compared with healthy controls (174). Variations in findings may
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relate to redundant regulatory mechanisms in the cerebral circulation, heterogenous
receptor densities across the vascular bed (e.g., a-adrenergic receptors, b-adrenergic
receptors), confounding changes in perfusion pressure, and methodological approaches
for measuring cerebral blood flow (29). While the role of the sympathetic nervous system
in regulating resting cerebral blood flow in humans remains controversial, numerous
studies have demonstrated its involvement in cerebral autoregulation (see Section
1.3.4.2).
The cerebral vessels receive parasympathetic innervation, yet limited data exist regarding
its role in resting cerebral blood flow. Following stimulation of the sphenopalatine
ganglia in rats (131, 165) and the major petrosal nerve (synapses in sphenopalatine
ganglia) in dogs (50), large increases in cerebral blood flow were reported. Further,
removal of the sphenopalatine ganglia in rats elicited reductions in resting cerebral blood
flow by approximately 28% while blood pressure was unaltered (26). Therefore, in
animals, parasympathetic nerves innervating cerebral arteries contribute to vasodilation
and resting cerebral blood flow. Limited data exist regarding the effect of
parasympathetic innervation on resting cerebral blood flow in humans. One hypothesis in
Alzheimer’s disease relates to impaired function of cholinergic nerves (179). Alzheimer’s
disease patients who received treatment with cholinesterase inhibitors (approximately 4
months) demonstrated increased regional cerebral blood flow (38). This investigation
provides evidence that in humans, muscarinic mechanisms may contribute to resting
cerebral blood flow. In patients with ischemic stroke, stimulation of a neurostimulator
electrode implanted into the pterygopalatine canal near the sphenopalatine ganglia,
produced an increase in ipsilateral common carotid artery diameter, flow velocity, and
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flow volume suggesting that parasympathetic innervation may contribute to resting
cerebral blood flow (153). Beyond resting cerebral blood flow, parasympathetic
innervation plays a role in pathological conditions including ischemia (74). In animals, it
is well documented that the parasympathetic nerves have a protective role in ischemia
with respect to cerebral blood flow and infarct size (28, 93, 103).

1.3.3.1

Sympathetic Blockade: Phentolamine

Sympathetic effects on the cerebral vasculature can be assessed through pharmacological
interventions that block neurotransmitters from binding to their receptors. Phentolamine
represents a non-selective a-adrenergic antagonist that is generally administered through
intravenous infusions. Phentolamine prevents norepinephrine from binding to
a-adrenergic receptors. Therefore, vasoconstriction, at least mediated through adrenergic
mechanisms, is prevented. While cerebrovascular constriction may still occur through
neuropeptide Y binding to Y1 receptors on the smooth muscle cells, animal studies report
that large cerebral arteries are densely innervated with a-1 adrenergic receptors (29).

1.3.4

Cerebral Autoregulation

Cerebral autoregulation describes the regulatory mechanism that protects cerebral
perfusion against fluctuations in blood pressure. Cerebral autoregulation was first
described by Niels Lassen in 1959 who observed that cerebral blood flow remained
relatively constant over a wide pressure range (111). This observation came after Lassen
merged data from seven different studies reporting on 11 unique groups including healthy
adults, pregnant women, and hypertensives (111). Nonetheless, the original cerebral
autoregulation curve was developed which demonstrated stable cerebral blood flow
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within a pressure range of approximately 50 mmHg to 150 mmHg. This view of
autoregulation persisted for many years and similar curves have since been demonstrated
but with slight variations in the pressure range (49, 109, 182, 212).
In 1989, shortly following the use of transcranial Doppler ultrasound for monitoring
blood velocity in the intracranial arteries, Aaslid and colleagues (1) made the observation
of dynamic cerebral autoregulation in humans. Compared to static cerebral
autoregulation, where more gradual changes in blood pressure are sustained over longer
durations, dynamic cerebral autoregulation relates to transient and rapid alterations in
blood pressure (172). With static approaches, measures of cerebral blood flow are taken
under steady-state conditions before and following a change in blood pressure generally
induced by pharmacological interventions (172). On the other hand, with transient
alterations in blood pressure, such as those experienced upon changing postures,
measures of cerebral blood flow are collected throughout the alteration (1, 172). The first
report of dynamic cerebral autoregulation challenged Lassen’s curve of autoregulation
because cerebral blood velocity initially tracked the transient change in blood pressure
before recovering to baseline levels (1). With advancement in analysis techniques,
specifically the adoption of non-linear approaches to cerebral autoregulation, a plateau of
approximately 10 mmHg in width was observed when blood pressure oscillations
occurred at 0.03Hz (167). Therefore, it has become widely accepted that the true
autoregulation curve in healthy humans is marked by a relatively narrow plateau region.
Two important characteristics of cerebral autoregulation have been identified in humans.
First, cerebral autoregulation functions as a high pass filter whereby lower frequencies of
blood pressure oscillations (< 0.07 Hz) are more effectively countered compared with
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higher frequency oscillations (> 0.07 Hz) (23, 206). Therefore, under conditions where
blood pressure oscillates at higher frequencies, these oscillations are likely to produce
fluctuations in cerebral blood flow (23). Second, cerebral autoregulation is marked by
hysteresis where the brain is more effective at defending against acute hypertension
compared with acute hypotension (178).
The ability to maintain cerebral blood flow at relatively constant levels despite alterations
in blood pressure depends upon rapid adjustments to cerebrovascular resistance mediated
by changes in vessel diameter. Three mechanisms have been shown to contribute to
vascular resistance adjustments underlying autoregulatory responses. These include
myogenic, neural, and metabolic mechanisms which are discussed below.

1.3.4.1

Myogenic Mechanisms of Cerebral Autoregulation

The myogenic response represents a mechanical mechanism sensitive to changes in the
transmural pressure gradient (i.e., the difference between extravascular pressure and
intravascular pressure). With an increase in intravascular pressure or a decrease in
extravascular pressure, the myogenic mechanism produces vessel constriction. In
contrast, with a decrease in intravascular pressure or increase in extravascular pressure
the myogenic mechanism elicits vasodilation. The myogenic response occurs rapidly with
the change in vessel diameter initiated within seconds from the stimulus (119). Calcium
(Ca2+) channels play an important role in the myogenic response. Following increased
arterial pressure (or decreased extravascular pressure), stretch-induced depolarization
opens voltage-gated Ca2+ channels permitting an influx of Ca2+ into smooth muscle cells
and initiating signaling cascades for vascular contraction (42).

31

Myogenic mechanisms contribute importantly to cerebral autoregulatory responses in
humans. Early studies in human isolated cerebral arteries demonstrated that increases in
intraluminal pressure produced reductions in vessel diameter when the artery was isolated
in a solution containing calcium but a passive increase in diameter was observed when
the solution did not contain calcium (186). In vivo human evidence further supports this
notion whereby ingestion of nimodipine to block Ca2+ channels increased transfer
function conductive gain and decreased phase, both indicative of impaired autoregulation
(176). Further, Tan and colleagues (168) demonstrated impaired autoregulation following
Ca2+ channel blockade when blood pressure fluctuations occurred at 0.03 Hz.
Specifically, following the infusion of nicardipine to block L-type Ca2+ channels, transfer
function gain was increased and the autoregulatory range (plateau region) was
significantly narrowed relative to control conditions (168). Given its rapid response,
myogenic reactivity appears to be a primary contributor to cerebral autoregulatory
adjustments in cerebrovascular resistance (75).

1.3.4.1.1

Myogenic Blockade: Nicardipine

The role of myogenic mechanisms on the vasculature can be addressed through the
blockade of Ca2+ channels. Nicardipine represents a Ca2+ channel blocker commonly
prescribed for treatment of hypertension. More precisely, a dihydropyridine Ca2+
antagonist (107), nicardipine represents an L-type Ca2+ channel blocker; L-type Ca2+
channels are voltage-gated Ca2+ channels located on vascular smooth muscle (117). Due
to its action of blocking voltage-gated Ca2+ channels, nicardipine produces vasodilation
and reductions in blood pressure. Nicardipine effectively reduces systemic vascular
resistance and blood pressure in hypertensive patients (16, 102, 185). Similar
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hemodynamic effects have been reported in the cerebral circulation where nicardipine
produced vasodilation in patients with vasospasm (17, 116) and in older men (44).

1.3.4.2

Neural Mechanisms of Cerebral Autoregulation

Given the highly debated role of the autonomic nervous system in resting conditions, its
contribution to cerebral autoregulatory processes is of interest. Sympathetic innervation
of cerebral vessels contributes importantly to cerebral autoregulation. Early studies in
animals demonstrated that sympathetic innervation plays a key role in regulating cerebral
blood flow during hypertensive conditions. In cats, sudden hypertension produced
increased cerebral blood flow, that was more pronounced in the hemisphere in which the
sympathetic nerves (superior cervical ganglia) were cut, relative to the hemisphere in
which the sympathetic nerves were stimulated (34). Based on these findings, as well as
similar findings (61, 81, 122) it was identified that the sympathetic nervous system acted
as a protective mechanism during hypertensive conditions. Years later, Cassaglia and
colleagues (36) directly measured sympathetic nerve activity from the superior cervical
ganglia in anesthetized lambs. Hypertension induced with phenylephrine, angiotensin II,
and adrenaline infusion as well as mechanically induced produced marked increases in
sympathetic nerve activity from the superior cervical ganglia (36). In contrast, with
hypotension induced by sodium nitroprusside infusion, no changes in sympathetic nerve
activity were recorded (36). Therefore, this study extends the earlier findings by
demonstrating increased cerebral sympathetic neural activity with hypertension,
confirming that the sympathetic nerves serve as protection against excessive perfusion
and damage to the cerebral microcirculation (34, 36, 61, 81, 122).
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In humans, Zhang and colleagues (207) examined the impact of ganglionic blockade on
dynamic cerebral autoregulation. Trimethaphan to block ganglionic transmission
produced a significant increase in autoregulatory gain along with a decrease in phase in
the very low frequency range (0.02-0.07 Hz) suggesting impaired cerebral autoregulation
(207). Further, Kimmerly and colleagues (99) demonstrated that inhibition of
a-adrenergic receptors led to impairments in cerebral autoregulation. Specifically,
norepinephrine infusion increased blood pressure while middle cerebral artery velocity
remained steady (99). In contrast, subsequent infusion of phentolamine (a-adrenergic
antagonist) produced alterations in middle cerebral artery blood velocity that followed
changes in blood pressure (99). In another study employing phentolamine infusion to
block sympathetic effects on the vasculature, blood pressure oscillations were induced at
varying frequencies using lower body negative pressure (76). Phentolamine impaired
cerebral autoregulation (increased transfer function gain) in the frequency range of
0.06-0.08 Hz (76). Finally, in a study conducted in patients with type 1 diabetes, no
difference in dynamic cerebral autoregulation was found between healthy controls and
type 1 diabetics; however, individuals with autonomic neuropathy showed impaired
autoregulation (133). Therefore, evidence from numerous models suggest that
sympathetic innervation contributes to cerebral autoregulation and is particularly
dominant under hypertensive conditions.
Evidence regarding the role of parasympathetic innervation in cerebral autoregulation
remains limited. Nonetheless, an investigation in humans demonstrated that infusion of
glycopyrrolate to block acetylcholine binding to endothelial muscarinic receptors,
increased autoregulatory gain (impaired autoregulation) when blood pressure oscillations
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were induced at a frequency of 0.06-0.08 Hz (77). Although cholinergic innervation
contributed to a lesser degree to overall cerebral pressure-flow relationships relative to
the sympathetic nervous system, it remained a significant contributor particularly to the
upper limit of autoregulation (75).

1.3.4.3

Metabolic Mechanisms of Cerebral Autoregulation

Carbon dioxide represents a major modifier of cerebral autoregulation in humans. In the
original study on dynamic cerebral autoregulation, Aaslid and colleagues (1)
demonstrated the impact of varying PETCO2 on autoregulatory responses to transient
blood pressure reductions. During hypercapnia, dynamic cerebral autoregulation was
impaired relative to control conditions whereas under hypocapnic conditions, dynamic
cerebral autoregulation was markedly improved compared with normocapnia (1). The
effect of carbon dioxide on autoregulatory responses relates to the baseline effect of
carbon dioxide on cerebrovascular tone (127). Additionally, studies have addressed how
hypercapnia and hypocapnia affect the lower limit of autoregulation, the upper limit of
autoregulation, and consequently the plateau region of the autoregulation curve in
animals. Under hypercapnic conditions, the lower limit of autoregulation appears to shift
to the right towards higher pressures in dogs (72) while the upper limit of autoregulation
shifts left towards lower pressures in dogs (55) narrowing the plateau region of the curve
(127). During hypocapnia, the lower limit of autoregulation does not appear to shift
significantly in dogs (15) while the upper limit of autoregulation is hypothesized to shift
right to higher pressures (127, 145) widening the plateau region (127). However, the
impact of hypercapnia and hypocapnia on the shape of the autoregulatory curve has not
been fully addressed in humans.
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1.3.4.4

Sit-to-Stand for Dynamic Cerebral Autoregulation

In the original investigation of dynamic cerebral autoregulation, Aaslid and colleagues
(1) employed a thigh-cuff model to elicit rapid and transient reductions in blood pressure.
With the thigh-cuff approach, two large cuffs are placed around the left and right thighs
and inflated to supra-systolic levels for 2-minutes after which the cuffs are rapidly
deflated (1). While the thigh-cuff model permits testing individuals in the supine posture,
there are limitations with the approach including variability in the blood pressure drop
between trials, need for multiple trials, and participant discomfort (118, 164). Lipsitz and
colleagues (118), employed a sit-to-stand technique as an alternative to the thigh-cuff
model. The sit-to-stand technique produced similar blood pressure responses to the thighcuff model but was more tolerable for participants and was a more relevant physiological
stimulus (118). Further, the sit-to-stand model produced similar values to the thigh-cuff
approach for the autoregulatory index, yielded lower within-participant variability
between trials compared with the thigh-cuff model (164), and was employed successfully
in older adults (118). Therefore, the sit-to-stand model represents a robust stimulus for
the quantification of dynamic cerebral autoregulation.

1.3.5

Neurovascular Coupling

An intimate anatomical relationship exists between the blood vessels, neurons, and
astrocytes in the brain to support optimal brain function. Termed the neurovascular unit,
the functional coupling between these structures is vital to the delivery of energy
substrates including oxygen and glucose (88). Neural activity elicits rapid increases in
blood flow to the region of activation (37). This functional hyperemic response was first
identified in 1880 by Angelo Mosso who observed increases in brain blood volume
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following emotional stimuli in patients with skull defects (87). Two main models of
functional hyperemia have been identified. First, a feedforward model describes that the
increase in regional cerebral blood flow relates to the release of vasoactive mediators
(e.g., nitric oxide, potassium, prostaglandins) from neurons during neural activity (85,
88). Second, a feedback model considers increased regional blood flow may be related to
i) energy demands of active neurons (37, 85) and ii) clearance of metabolic by-products
of neural activity including lactate and carbon dioxide (85, 88). Studies supporting both
models (discussed below) suggest that metabolism-dependent and independent processes
may contribute to the functional hyperemic response and may depend on magnitude and
duration of activation as well as the brain region (88).
Based on the feedforward model, neurons release vasoactive mediators that can act on
the vasculature directly or elicit vasoactive effects indirectly (88). Glutamate released by
neurons binds to post-synaptic neuronal receptors eliciting increased intracellular Ca2+
concentrations (68, 88) which activate neuronal nitric oxide synthase and
cyclooxygenase-2 (88) to produce nitric oxide and prostaglandins, respectively.
Exogenous sources of glutamate produce vasodilation of cerebral arteries in rats and
rabbits (59, 120) while glutamate receptor inhibitors attenuate the cerebral blood flow
response to stimulation in rats (6, 135) providing evidence that glutamate contributes to
functional hyperemia. Further, inhibition of nitric oxide synthase (NG-nitro-L-arginine or
NG-nitro-L-arginine methyl ester) attenuated the cerebral blood flow response following
exogenous glutamate in rabbits (59) and neural activation by electrical or whisker
stimulation in rats (6, 89, 115, 139). Similar findings have been demonstrated with
cyclooxygenase whereby the cerebral blood flow response following neural activation
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was attenuated in cyclooxygenase-2 null mice (136) and following inhibition of
cyclooxygenase-2 in mice and rats (126, 136). Additionally, increases in extracellular
potassium, related to ionic currents with neuronal activity, contributes to functional
hyperemic responses by acting directly on the vasculature. Specifically, in rats,
vasodilation mediated by electrical stimulation was attenuated by approximately 71%
when voltage-dependent inward rectifying potassium channels were inhibited with
barium ions (64). Therefore, feedforward processes related to neuronal activity play a
role in facilitating functional hyperemia.
Feedback models of neurovascular coupling implicate energy substrates (e.g., oxygen)
and metabolic by-products in mediating functional hyperemia. The temporal dynamics of
tissue oxygen and cerebral blood flow following forepaw stimulation was evaluated in
rats. Here, a decrease in tissue oxygen levels were recorded prior to the initiation of
increases in cerebral blood flow (13). Observation of capillary dilation prior to arterial
dilation (73) and increases in capillary red blood cell velocity prior to arterial hyperemia
(189) provide evidence that functional hyperemia is initiated in the capillaries in rats and
mice. Wei and colleagues (189) observed that dips in oxygen following neural activity
were necessary for increasing red blood cell velocity in the capillaries of mice. Further,
this study demonstrated that red blood cells were important for capillary hyperemia and
increasing arterial diameter (189). Additionally, with neuronal activity, adenosine
triphosphate (ATP) sources may become depleted leading to activation of ATP sensitive
potassium channels (68). In rats, blockade of ATP sensitive potassium channels
attenuated the dilatory response to elevations in potassium (134) suggesting their role in
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feedback processes. Therefore, feedback mechanisms initiated by reductions in oxygen
and ATP also play a role in functional hyperemia.
Astrocytes are important intermediaries in neurovascular coupling (146) given they
receive projections from neurons and interneurons and they are in direct contact with
blood vessels (74). Glutamate released from neurons can bind to receptors on astrocytes
leading to a rise in intracellular Ca2+ (63, 209). Increased Ca2+ activates cyclooxygenase
leading to the production and release of prostaglandins from astrocytes (209). Following
the injection of astrocyte glutamate receptor antagonists in rats, the stimulation-mediated
hyperemic response was reduced (208). Further, this study in rats identified that
cyclooxygenase inhibitors reduced arteriolar dilatory responses to direct astrocyte
activation, application of astrocyte glutamate agonists, and neuronal stimulation (208).
These findings confirm that astrocytes importantly modulate the functional hyperemic
response through glutamate-mediated increases in astrocytic Ca2+ concentrations
activating cyclooxygenase and subsequently the production and release of prostaglandins.
Astrocytes also mediate the role of potassium in functional hyperemia. More precisely,
astrocytes take up potassium released by neurons and subsequently release the potassium
at the end feet to act directly on the vessels eliciting vasodilation (144). This potassium
“siphoning” mechanism increases potassium concentrations at the arterioles more rapidly
(compared to diffusion) given the direct contact between the astrocyte end feet and blood
vessels (144).
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1.4 Vascular Compliance
Vascular compliance refers to the elasticity of blood vessels and is provided by the
following equation:

[7] 𝐶𝑜𝑚𝑝𝑙𝑖𝑎𝑛𝑐𝑒 =

∆1
∆2

where V represents arterial blood volume and P represents distending blood pressure.
Studies will commonly assess compliance using vessel cross-sectional area or diameter as
an alternative to volume (69). For a given distending pressure, if the vessel can
accommodate more blood volume, the vessel demonstrates greater vascular compliance.
Vascular compliance represents an important component of pulsatile blood flow in the
human cardiovascular system. The heart acts as a pump ejecting blood into the aorta;
however, the heart only pumps blood into the aorta during systole with no flow during
diastole. Therefore, blood flow entering the aorta, and hence the driving pressure, are
intermittent and not continuous (201). But the distensible vasculature acts as a
Windkessel or a reservoir to temporarily store blood volume during systole (201).
Additionally, a portion of the driving energy is stored in elastic arteries as they distend,
and during diastole, in the absence of a driving force, the vessels recoil and the energy
drives the blood forward (201). As a result, vascular compliance contributes to
continuous blood flow through the entire arterial tree. Only 30-40% of blood ejected into
the aorta during systole is pushed forward through the vasculature due to downstream
vascular resistance while the remaining 60-70% is temporarily stored in the elastic
arteries and subsequently driven forward during diastole (69). Vascular compliance also
contributes to a pressure damping effect (69). Vessel distension during systole provides a
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cushion to absorb some of the pressure of the blood being driven into the elastic arteries
(i.e., systolic blood pressure). Additionally, during diastole, when cardiac ejection ceases
and blood pressure begins to fall off, the recoiling action of the arteries helps to maintain
a healthy diastolic blood pressure contributing to forward blood flow during diastole.
Therefore, compliance represents a primary determinant of oscillatory blood pressure and
blood flow.
The factors contributing to the expression of vascular compliance are complex and
presented in a schematic in Figure 1.2. Largely, vascular compliance depends on the
proportions of the structural elements of the vascular wall, particularly elastin, collagen,
and smooth muscle cells. These elements contribute to vascular wall tension which
counters the distending force produced by blood pressure to maintain equilibrium (33).
Total wall tension consists of i) elastic tension or maintenance tension related to the
stretch of the wall beyond its natural shape and ii) active tension related to the contraction
of smooth muscle cells and independent of the stretch of the vessel wall (33).
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Figure 1.2. Schematic of the factors contributing to the expression of vascular
compliance in the cerebral circulation.

Elastic tension or maintenance tension arises primarily from elastin and collagen fibers
(33). The shape of the volume-pressure curve is curvilinear (Figure 1.3) due to the
relative contribution of elastin and collagen to elastic wall tension or maintenance tension
at varying distending pressures and wall stretch (33). An investigation by Roach and
Burton (150) examined volume-pressure curves of ex vivo human iliac arterial segments
following autopsy. To determine the contribution of elastin and collagen to arterial
pressure-volume curves, the arterial segments were treated with either formic acid to
remove collagen or crude trypsin to remove elastin (150). Under normal conditions,
typical pressure-volume curves were observed with a gradual decreases in distensibility
as the wall becomes increasingly stretched at higher pressures (150). Following the
removal of elastin, vessel collapse occurred with relatively small degree of negative
pressure (1-2 mmHg vs. 5-10 mmHg in untreated vessels) while at high pressures no
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differences were observed from the original volume-pressure curve (150). After depletion
of collagen, a linear relationship between volume and pressure was recorded, whereby the
initial slope (i.e., at low pressures) was unaltered but significant deviations from the
typical curve were viewed at higher pressures (150). Therefore, under conditions of low
distending pressure and wall stretch, elastin fibers predominantly contribute to
maintaining wall tension (33). Due to the high extensibility of elastin fibers, blood
vessels will exhibit greater vascular compliance. With increased distending pressure and
greater stretch of the vessel wall, collagen fibers will become stretched and support wall
tension while providing resistance against hypertension (33). Because the extensibility of
collagen fibers is profoundly less than that of elastin, the stretched collagen fibers will
contribute to reductions in vascular compliance.

Figure 1.3. A theoretical volume-pressure curve of human arteries. Under conditions of
low blood pressure, the slope of the curve is steeper representing greater vessel
compliance (A). Under conditions of high blood pressure, vascular compliance is reduced
as depicted by the lesser slope (B).
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Smooth muscle cells contribute to wall tension by providing active tension, independent
of distending pressure or stretch of the vessel wall (33). Active tension in smooth muscle
may i) resist stretch or vessel distension producing reductions in vascular compliance
(52) or ii) through contraction may return elastin and collagen to their unstretched lengths
and the vessel would express greater compliance (i.e., elastin would have a high degree
of extensibility restored and collagen fibers would not be stretched) (33). As such, the
role of smooth muscle in determining vascular compliance is complex but smooth muscle
does resist high pressure conditions by providing active tension (33).
Considerable research has explored the contribution of smooth muscle contractile state to
vascular compliance. Early reports in animals have provided conflicting results. In
anesthetized dogs, epinephrine was injected into isolated aortic segments and increased
aortic distensibility was observed following vessel constriction (10). Additionally, in a
study of ex vivo canine carotid arteries, Dobrin and Rovick (52) demonstrated that
vascular contraction, induced by norepinephrine, decreased the elastic modulus (i.e.,
increased compliance) when the elastic modulus was plotted against pressure supporting
the earlier findings in anesthetized dogs. However, Dobrin and Rovick (52), also found
that when the elastic modulus was plotted against strain (i.e., deformation) instead of
pressure, the opposite was true whereby the elastic modulus was increased (i.e.,
decreased compliance) with norepinephrine. This paradoxical finding relates to two
concepts: i) when plotted against pressure, the smaller vessel radius would bring elastin
and collagen to their unstretched lengths which would enable the highly extensible elastin
to support wall tension and this effect would persist across a large range of pressures (33,
52) and ii) when plotted against strain, across a range of strains the smooth muscle is

44

expected to provide resistance against deformation (52). Therefore, this study highlights a
key methodological consideration whereby differential changes are reported dependent
on whether vascular mechanics are plotted against pressure or strain. Additionally, the
investigators highlight that the effect of active smooth muscle on vascular compliance
may depend upon the ability of a blood vessel to contract (52) which in turn is affected
by baseline tone of the vessels. Human studies also highlight the complex relationship
between vascular smooth muscle and compliance. Bank and colleagues (18) highlight
that vessel compliance depends on changes in both vessel geometry and wall stiffness or
more precisely, the balance between changes in these factors. Existing human data in the
peripheral circulation demonstrate that smooth muscle contributions to vascular
compliance appear to act largely through changes in wall stiffness. Specifically, increased
forearm arterial (brachial and/or radial) compliance or distensibility was observed
following relaxation of smooth muscle cells by nitroglycerin (19, 21, 163, 191), brachial
plexus blockade (57, 70), or denervation (65). Further, activation of smooth muscle cells
through phenylephrine administration (70), cold pressor tests (25, 152), mental stress
(25), or lower body negative pressure (152) decreased brachial or radial arterial
compliance or distensibility. Indeed, some of these human studies demonstrated no
change in diameter with the changing smooth muscle tone (25, 57, 70, 152) suggesting
that wall stiffness produced the changes in vascular compliance. Further, findings of
reduced vessel diameter (with phenylephrine) and reduced vessel compliance (70) also
demonstrate that the increase in wall stiffness played a larger role in vessel compliance
relative to the change in vessel diameter. Importantly, these findings are measured in the
peripheral circulation where sympathetic innervation produces resting vascular tone that
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is more constricted relative to the cerebral circulation. Bank and colleagues (20) also
highlight an additional complexity through observation of varied effects of smooth
muscle cell contraction on brachial artery elastic modulus (inverse of compliance)
whether isobaric or isometric contractions were elicited. With isometric smooth muscle
contractions, the elastic modulus of the brachial artery increased (decrease in compliance)
(20) consistent with some of the above findings (25, 57, 70, 152) as wall stiffness is
altered independent of vessel geometry. Under conditions of isobaric smooth muscle
contractions, the elastic modulus remained unchanged (20). Additionally, Bank and
colleagues (18) report that under conditions where significant changes in vessel geometry
occur, the relationship between vessel compliance and elastic modulus as well as
distensibility also changes. Therefore, the effect of smooth muscle cells on compliance of
the arteries is complex. Overall, it appears that many factors can influence this
relationship including i) resting or baseline contractile state of the vessels and their
subsequent ability to change diameter in either direction, ii) how the vessel wall
properties are calculated (i.e., compliance or elastic modulus), iii) whether wall stiffness
and/or vessel geometry are affected, and iv) whether the wall properties are compared
against pressure or strain.
In addition to the structural elements of the vascular wall, heart rate plays an important
role in determining vascular compliance. The effect was first reported in vivo in
anesthetized rats wherein tachycardia induced by atrial pacing caused reductions in
carotid artery compliance (123). This finding has been replicated in humans in which
Liang and colleagues (114) demonstrated that transesophageal atrial pacing reduced
systemic arterial compliance in healthy adults. Further, Giannattasio and colleagues (66)
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studied patients with an implanted pacemaker demonstrating reduced carotid and radial
artery distensibility with atrial pacing. Tachycardia can be accompanied by increases in
blood pressure which may contribute to the reduction in compliance observed in the
previous studies. However, Liang and colleagues (114) employed two paced trials (80
and 100 beats per minute) and found no difference in blood pressure between the two
trials yet a reduction in arterial compliance. In the study by Giannattasio and colleagues
(66), blood pressure remained unaltered with atrial pacing at 90 and 110 beats per minute.
Additionally, a study conducted by Cunha and colleagues (48) examined relationships
between carotid distension and heart rate in a large sample of 536 participants, including
healthy normotensive adults and hypertensive patients. A negative correlation was
observed between carotid distension and heart rate which persisted following adjustment
for blood pressure (48). Therefore, heart rate effects vascular compliance independent of
potential blood pressure changes associated with increased heart rate. An additional
hypothesis suggests the reduced distensibility may stem from reflex-mediated increases
in sympathetic nerve activity triggered by reduced stroke volume associated with the
tachycardia (66). While stroke volume was decreased in response to atrial pacing in the
study by Liang and colleagues (114), animal work demonstrated similar tachycardiamediated reductions in carotid distensibility following sympathectomy suggesting that
increased sympathetic activity did not contribute to the reduced distensibility (129).
Therefore, reductions in arterial compliance with increases in heart rate likely relate to
the viscoelastic and inertial properties of the vessel wall. Due to these properties, vascular
distensibility depends upon the duration of the cardiac cycle; when the length of time the
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vessel has to distend becomes reduced, the magnitude of vessel distension is attenuated
and the vessel behaves more rigid (48, 66, 123).

1.4.1

Methods of Quantifying Vascular Compliance

In early investigations, quantification of vascular compliance relied on ex vivo techniques
or invasive in vivo approaches. Various non-invasive in vivo techniques have been
adapted enabling quantification of vessel compliance, either directly or indirectly. Here
we will focus on methods employed in human studies.
As stated previously, compliance represents the change in volume for a given change in
pressure. As an alternative for changes in volume, change in vessel diameter or cross
sectional area can be substituted into the equation (69). The most common non-invasive
approach applied in humans consists of ultrasound techniques to measure vessel diameter
and finger photoplethysmography to measure arterial blood pressure (25, 70). For both
diameter and pressure, the change is calculated between systole and diastole. Measures of
distensibility are commonly calculated as an alternative to compliance (57, 65, 152) as
distensibility assesses the relative change in vessel diameter (69). Therefore, distensibility
would be a beneficial approach when comparing groups where baseline diameter may
differ and/or in comparing between experimental conditions where baseline diameter is
affected.
Vascular compliance and distensibility both examine the extensibility of the vessel wall.
In contrast, the inverse, stiffness, can be measured and used to provide indirect
information on vessel compliance. Two common measures of arterial stiffness include the
elastic modulus and pulse wave velocity. The elastic modulus evaluates the change in

48

stress (force per unit area) for a given change in strain (change in area relative to initial
area) (69) while pulse wave velocity evaluates the velocity of the pulse wave travelling
through the vasculature, typically measured between two sites such as the carotid and
femoral arteries (32). Therefore, from studies that report changes in the elastic modulus
or pulse wave velocity we can generally infer an opposite change in vascular compliance.
Windkessel models represent an additional non-invasive approach for the calculation of
vascular compliance. Windkessel models are mathematical models that incorporate
vascular compliance and resistance features thereby considering the Windkessel
behaviour of elastic arteries. In 1899, Otto Frank developed the two-element Windkessel
model to calculate cardiac output; total arterial compliance was estimated from pulse
wave velocity and the aortic pressure decay time was provided by the product of
peripheral resistance and compliance (190). Since the first application, the Windkessel
model has undergone modification by the addition of elements which commonly includes
impedance, inertia, or additional resistors (190). Variations on the characteristic
Windkessel model are referred to as modified Windkessel models.

1.4.1.1

RCKL

The studies in the present thesis employed a four-element modified lumped parameter
Windkessel model (RCKL). The four elements that are incorporated into this model are
resistance (R), compliance (C), viscoelasticity (K), and inertia (L). The lumped parameter
concept substitutes the complex structure of an arterial vascular bed with a single tube
that encompasses the properties of the entire vascular bed (201). The relationship
between the pressure and flow waveforms that are measured at the entrance to a vascular
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bed (e.g., aorta) can provide information on the state of the vascular bed as a whole (e.g.,
total systemic compliance) (190, 201).
Composite blood pressure waveforms can be decomposed into their harmonics, that is, a
series of sine and cosine waves that summate to form the composite waveforms (201).
When input to the model, the measured blood pressure waveform is decomposed into its
harmonics and a flow harmonic is predicted for each pressure harmonic based on the
equation:

[8] 𝑞 =

2
3

where q represents the flow harmonic, p the pressure harmonic, and Z the total impedance
of the system (203). The total impedance is defined as:

[9] 𝑍 =
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where R is resistance, w is oscillatory frequency, K is viscoelasticity, C is compliance, i is
√−1, and L is inertia (203). To determine impedance, R is first calculated as the quotient
of mean pressure and mean flow over the oscillatory cycle:

[10] 𝑅 =

"@
'

where 𝑃& is mean pressure and Q is mean flow (203). Then, initial values for C, K, and L
are set (𝐶! , 𝐾! , 𝐿! ) to provide Z, and a flow harmonic is predicted (203). This process is
completed for each pressure harmonic, until the predicted flow harmonics are
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reassembled into a predicted flow waveform (composite waveform) (202). The model
predicted flow waveform is compared to the measured flow waveform and the degree of
agreement between the two waveforms is calculated as an error value (203):
;

[11] 𝐸 = @ % ∑;BB
∆𝑞A.
AC;
'
The error assesses the differences between the predicted and measured flow waveforms at
each time constant, 𝑗 (= 1 ∙∙∙ 100), within the time normalized oscillatory cycle (203). To
reduce the error between the two waveforms, the values of C, K, and L are changed in an
iterative fashion (203). The parameters are altered one at a time; while K and L are held
at 𝐾(= 𝐾! ) and 𝐿 (= 𝐿! ), C is changed to a range of values around 𝐶! until a minimum
error value is reached and 𝐶 = 𝐶" (203). Next, while C and L are held at 𝐶 (= 𝐶" ) and
𝐿 (= 𝐿! ), K is changed to a range of values around 𝐾! to find the minimal error value at
which K is set at 𝐾 = 𝐾" (203). Finally, while C and K are held at 𝐶 (= 𝐶" ) and
𝐾 (= 𝐾" ), L is changed to a range of values around 𝐿! to find the value 𝐿 = 𝐿" with the
minimum error (203). With this, the first iteration (𝐶" , 𝐾" , 𝐿" ) is substituted into equation
[9] to provide a model-predicted flow waveform with closer agreement to the measured
flow waveform (smaller error). This process is repeated to find (𝐶# , 𝐾# , 𝐿# ), (𝐶$ , 𝐾$ , 𝐿$ ),
and continued up to 1,000 iterations. With each iteration, the minimum error value is
determined with a higher accuracy (203). The process will end upon reaching a
prescribed accuracy at which point the values of C, K, and L are representative of the
properties in the vascular bed (203). In other words, the values of C, K, and L that
provide the predicted flow waveform that most closely matches the measured flow
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waveform are the values we would expect to measure in the vasculature in vivo. An
example of the model output is shown in Figure 1.4.

Figure 1.4. An example of the output from the RCKL model. The measured flow
waveform input into the model is depicted by the red solid line and the model-predicted
flow waveform is depicted by the blue dashed line. Values for resistance (R), compliance
(C), viscoelasticity (K), inertia (L), mean pressure, mean flow, and the error (E) are
shown.
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The RCKL model, like all Windkessel models, is a simplified model of an arterial
vascular bed (202). As such, the model is not expected to produce a waveform with
perfect agreement to the measured flow waveform (202). Rather, we focus on attaining
good agreement between the predicted and measured flow waveforms at the foot of the
upstroke. Additionally, because the model is a simplified representation, we focus on the
change in values of C, K, and L rather than absolute values (202).

1.5 Cerebrovascular Compliance
The complex relationship between the factors determining vascular compliance becomes
further complicated by the encasement of the cerebral circulation within a pressurized
skull. This creates an environment where the blood vessels are exposed to external
sources of pressure termed intracranial pressure. Intracranial pressure contributes to the
transmural pressure gradient and will affect how distending pressure and wall stretch
impact vascular compliance. Hu and colleagues (86) aimed to address the effect of
intracranial pressure on vascular compliance by simulating the pressurized environment
in an animal kidney. A rabbit kidney was placed in a fluid filled container with a port that
could be opened or closed (86). Vessel compliance was lower in the closed container
state relative to the open container state suggesting that compliance of the intracranial
compartment influences vascular mechanics (86). A recent study in our laboratory
provided further evidence that the pressurized environment restricts compliance of the
cerebral vasculature by comparing the impact of modelled alterations in vascular
compliance on flow velocity waveforms in the peripheral vasculature (forearm) and the
cerebral vasculature (203). In the forearm vascular bed, modelled increases in compliance
increased the amplitude of the flow velocity waveform while reductions in compliance
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decreased the amplitude of the flow velocity waveform (203). In the cerebral vascular
bed, modelled increases in compliance increased the amplitude of the flow velocity
waveform but reductions in compliance had no effect on the flow velocity waveform,
suggesting that cerebrovascular compliance operates at the lower end of its natural range
(203).
The study of cerebrovascular compliance has emerged in the last 15 years. Due to access
difficulties imposed by the skull, investigation of cerebrovascular compliance relies on
advanced imaging techniques and/or modelling approaches. Imaging approaches
including arterial spinal labelling (187, 199), cardiac triggered T2-weighted images with
7T MRI (188), and diffuse optical imaging (166), have permitted quantification of
compliance of the cerebral vasculature under resting conditions. Arterial spin labelling
provides calculation of cerebral arterial blood volume, and in combination with blood
pressure measured at the brachial artery, cerebral arterial compliance is determined as the
quotient of the change in blood volume between systole and diastole to the change in
brachial blood pressure between systole and diastole (187, 199). Additionally,
Windkessel models can be combined with imaging techniques (56, 84) or can be used
independently (203) to evaluate cerebrovascular compliance. For example, the change in
amplitude and volume load calculated from the pulsatile flow waveforms measured with
4D flow MRI are input into a two-element Windkessel model to determine cerebral
arterial compliance (84). While a number of studies have assessed cerebrovascular
compliance under resting conditions, the use of varying approaches and units of
measurement limits the comparison of studies.
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With the application of modelling approaches, studies have assessed the role of vascular
compliance in the dynamic regulation of blood flow. More precisely, studies have
provided evidence that vascular compliance contributes to dynamic cerebral
autoregulation (40, 176, 177, 205). During transient blood pressure alterations, single
resistance models as well as Windkessel models (resistance and compliance) were
employed to predict cerebral blood velocity responses from the blood pressure profile
(40, 176). The cerebral blood velocity response predicted with Windkessel models more
closely matched the measured cerebral blood velocity responses (40, 176). These findings
suggest that vascular compliance plays an important role in determining the blood
velocity responses during blood pressure alterations and as such contributes to cerebral
autoregulatory responses.
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Chapter 2

2

Rapid changes in vascular compliance contribute to
cerebrovascular adjustments during transient
reductions in blood pressure in young, healthy adults

Published in Journal of Applied Physiology 129(1): 27-35, 2020.

2.1 Introduction
During periods of transient blood pressure (BP) alterations, cerebrovascular adjustments
underlie the autoregulatory response that defends cerebral perfusion (1). To date,
characterization of autoregulation has focused primarily on alterations in cerebrovascular
resistance achieved by adjustments in vessel diameter through myogenic, metabolic,
and/or neural mechanisms. Indeed, impairments in cerebral autoregulation accompany
abnormal cerebrovascular resistance responses to deviations in BP (1, 4, 21). However,
solely focusing on cerebrovascular resistance conceals the contribution of broader
mechanical features of the cerebral circulation to dynamic cerebral blood flow regulation.
In contrast to vascular resistance, which reflects changes in vessel diameter, vascular
compliance represents the dynamic distension and recoiling action of the vasculature
during oscillatory changes in BP between systole and diastole, respectively. Vascular
compliance relies on the elastic properties of the vascular wall and forms a fundamental
property of oscillatory blood flow control (31). Importantly, our previous study of the
forearm vascular bed identified changes in vascular compliance, independent of
alterations in vascular resistance, during manoeuvres affecting myogenic and/or neural
regulation of the circulation (31). These data illustrate that vascular compliance and
resistance represent independent but complementary means of regulating blood flow (31).
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Here we address how cerebrovascular compliance and resistance contribute to cerebral
autoregulatory responses.
Compliance of an arterial vascular bed can be examined non-invasively with Windkessel
models using concurrent measures of BP and blood flow and known mathematical
relationships between their individual harmonics (13, 30-33). Previous investigations
applying Windkessel models to the cerebral vascular bed have proposed that compliance
contributes to cerebrovascular flow dynamics (9, 26, 27, 34). These earlier approaches
compared characteristic resistance-based models of cerebral autoregulation to Windkessel
models as predictors of cerebral blood velocity (BV) changes during transient increases
and decreases in BP; Windkessel models incorporating measures of vascular resistance
and compliance explained greater variation in BV (9, 26, 27) than single-resistance
models (9, 26). However, these studies did not examine within-cardiac cycle
cerebrovascular compliance or how these changes might relate temporally to changes in
vascular resistance during alterations in BP.
Hypotensive models of dynamic cerebral autoregulation, including sit-to-stand (19) and
thigh-cuff (4) protocols, are consistently associated with increased amplitude of the
oscillatory cerebral BV waveforms during the period of decreased BP. Importantly, the
increased amplitude of the BV waveforms appears to result from sustained systolic but
decreased diastolic BV components. Moreover, whereas myogenic, metabolic, and
neurally-mediated alterations in vascular resistance are expected to be associated with
slight delays due to signaling and transduction events, increased pulsatility of BV can be
observed immediately upon standing (19) or thigh-cuff release (4). These observations
suggest a rapid increase in cerebrovascular compliance which contrasts with the expected
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low to very low frequency dominance of resistance-based models (10). Therefore, the
cerebrovascular response to reductions in perfusion pressure may involve diverging
patterns in vascular compliance and resistance metrics.
Therefore, this research tested the hypothesis that cerebrovascular processes induced by
reductions in BP involve increases in cerebrovascular compliance contributing to the
preservation of systolic BV. The present study employed a Windkessel modeling
approach to quantify within-beat changes in cerebrovascular compliance and resistance
during transient reductions in BP induced by a sit-to-stand model.

2.2 Methods
2.2.1

Ethical Approval

The Health Sciences Research Ethics Board at Western University approved the study.
This study adhered to the standards of the Declaration of Helsinki, except for registration
in a database. Each participant provided informed, written consent following verbal and
written explanations of study procedures.

2.2.2

Participants

Nine (3 females) young, healthy adults (24 ± 4 years, 176 ± 10 cm, 68 ± 10 kg)
participated in the current investigation. Participants were normotensive, free of
cardiovascular disease or cardiovascular risk factors, free of respiratory disease or illness,
were not diagnosed with neurological disorders or major psychiatric conditions, and not
currently taking medications known to affect blood pressure or autonomic function.
Female participants were not on oral contraceptives, and we did not control for menstrual
cycle in the present study.
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2.2.3

Experimental Protocol

Prior to testing, participants fasted for at least 4 hours and abstained from caffeine and
alcohol consumption, and vigorous physical activity for 12 hours. Participants completed
a detailed medical history questionnaire and anthropometric measurements were
recorded. Participants voided their bladder prior to commencement of testing to minimize
the effect of bladder distension on blood pressure (12).
Participants were instrumented with a single-lead electrocardiogram (ADInstruments Bio
Amp FE132, Bella Vista, New South Wales, Australia) for continuous measurement of
heart rate (HR). Finger photoplethysmography (Finometer, Finapres Medical Systems,
Enschede, The Netherlands) collected continuous finger arterial BP from the left or right
hand. Brachial artery BP waves were reconstructed from finger arterial BP waves (6).
End tidal carbon dioxide partial pressures (PETCO2; n = 7) were monitored with a
respiratory gas analyzer (ML206, ADInstruments, Bella Vista, New South Wales,
Australia). Two participants did not wear a face mask which prevented measurement of
PETCO2. Participants wore a headband device that supported a 2 MHz pulsed wave
transducer (Neurovision TOC2M, Multigon Industries, Elmsford, CA, USA) for
insonation of the right middle cerebral artery (MCA) and collection of cerebral BV as the
instantaneous peak velocity. Data were sampled at 1,000 Hz with an online data
acquisition and analysis system (LabChart 8, PowerLab, ADInstruments, Bella Vista,
New South Wales, Australia) and stored for subsequent offline analysis.
Data were collected during a sit-to-stand protocol. Participants were fitted with a sling to
maintain their hand with the finger photoplethysmograph cuff in a fixed position at heart
level. The study began after stabilization of all cardiovascular and cerebrovascular
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variables for at least 5 minutes in a seated posture. During data acquisition, participants
rested in the seated position for three minutes then stood upright. To reach a fully upright
position required about 2-3 seconds. Following three minutes of standing, participants
returned to a seated position guided by researchers to avoid rotational head movement
during the transition. Upon resuming the seated position, three minutes of sitting was
performed before subsequent stand(s). The sit-to-stand protocol was performed twice to
evaluate reproducibility between stands. A third trial was performed in the case of
disturbances in the BP or TCD signal with standing (n = 2). Sitting and standing occurred
voluntarily without the use of hands during spontaneous breathing and poikilocapnic
conditions.

2.2.4

Data Analysis

Data analysis began 20 heart beats prior to the initiation of standing and continued for 40
beats following the initiation of standing. From the first beat (i.e., 20 heart beats before
standing), every second beat thereafter was selected so that a total of 10 beats of sitting
and 20 beats of standing were analyzed. Prior to input of data into the model, the BP
waveform was shifted back in time to match the foot of its corresponding BV waveform,
accounting for temporal delays between pressure pulse arrival at the MCA and brachial
artery (32). For each beat selected, cerebrovascular compliance and resistance were
calculated using the four-element lumped parameter modified Windkessel model as
reported earlier in our laboratory (32) and described in more detail below. Because the
modelled outcomes reflect BV and not true flow (no values of MCA cross-sectional area
were available in the current study), we report the primary outcomes as indexes of
cerebrovascular compliance (Ci) and resistance (Ri). In addition, the corresponding mean
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BP, systolic BP (SBP), diastolic BP (DBP), pulse pressure (PP), mean BV, systolic BV,
and diastolic BV were obtained for each selected beat. Seated baseline Ci was determined
as the average of the 10 beats of sitting. Subsequently, the change (∆) in Ci was
calculated as the difference between peak Ci (single beat, maximum value) and seated
baseline Ci. Additionally, the percent change in Ci was determined by dividing ∆Ci by
seated baseline Ci and multiplying by 100. In contrast, ∆Ri, indices of BP (i.e., mean BP,
SBP, DBP, PP) and BV (i.e., mean BV, diastolic BV) were calculated as the difference
between the nadir value (single beat, minimum value) and the average of seated baseline
values. PETCO2 was averaged during seated baseline and standing. Determination of the
number or beats or seconds to the start of change in BP, Ci, and Ri as well as the peak or
nadir values occurred from the initiation of standing. Two investigators determined the
number of beats to the start of change in BP, Ci, and Ri (MEM, SAK). An intraclass
correlation coefficient (ICC) was calculated to evaluate interrater reliability. A strong
agreement between the two investigators was observed (ICC = 0.96, P < 0.001) and a
single investigator’s selection was used for analysis. The Ci of each extracted beat was
correlated with corresponding PP, SBP, and DBP. Similarly, ∆Ci was correlated with
∆PP, ∆SBP, and ∆DBP. Additionally, seated baseline Ci was correlated with peak Ci.

2.2.5

Four-Element Lumped Parameter Modified Windkessel
Model

The four-element lumped parameter modified Windkessel model has been described in
detail previously (32). Briefly, four mechanical properties influence the relationship
between oscillatory pressure and flow waveforms in a vascular bed: resistance to the
steady component of flow, compliance, viscoelasticity, and inertia (32). Known
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mathematical relationships between individual harmonics of pressure and flow
waveforms (32) permit the computation of these properties of a vascular bed using
corresponding BP and flow waveforms measured at the entrance to that vascular bed.
First, the quotient of mean BP and mean flow over the cardiac cycle determines
resistance. Initial values of compliance, viscoelasticity, and inertia are prescribed to the
harmonics of the waveforms and the model predicts a flow waveform (i.e., reassembles
the harmonics into a complex waveform). Up to 1,000 iterations of modified values in
compliance, viscoelasticity, and inertia are performed to determine the minimal error in
the agreement between the model-predicted flow waveform and measured flow
waveform. The process ends upon reaching minimal error and the values of compliance,
viscoelasticity, and inertia are representative of the corresponding properties of the
vascular bed. In the present study, we focus on the values (indexes) of resistance (Ri) and
compliance (Ci). Analysis was performed using custom written software (Matlab,
MathWorks, Natick, MA, USA).

2.2.6

Statistical Analysis

Data were tested for normality using the Shapiro-Wilk test. Non-parametric tests were
used where appropriate as outlined below. A two-tailed Student’s paired t-test assessed
the difference between peak Ci and seated baseline Ci. To evaluate the delay between
changes in Ci and Ri, a two-tailed Student’s paired t-test assessed the difference in the
beat number corresponding to the increase and decrease of Ci and Ri, respectively. A
two-tailed Student’s paired t-test assessed differences in PETCO2 between seated baseline
and standing. Spearman’s rank order correlations evaluated the relationship between
hemodynamic variables (i.e., PP, SBP, DBP) and Ci for each beat analyzed (i.e., a total of

80

30 beats). Additionally, Spearman’s rank order correlations assessed the relationship
between the change in hemodynamic variables (i.e., ∆PP, ∆SBP, ∆DBP) and ∆Ci. A
Pearson product-moment correlation evaluated the relationship between seated baseline
Ci and peak Ci. Bland-Altman methods (3) and ICC assessed the agreement of seated
baseline Ci and ∆Ci between stand one and stand two. With the Bland-Altman analysis,
fixed and proportional bias were evaluated using a two-tailed Student’s paired t-test
(between variables from stand one and stand two) and linear regression (differences
regressed against means), respectively. Data are reported as means ± standard deviations.
Cohen’s d effect sizes were calculated. P ≤ 0.05 defined statistical significance.
Statistical analyses were performed using SPSS Statistics 25 (SPSS Inc., Chicago,
Illinois, USA) and SigmaPlot 12.5 (for Bland-Altman analysis; Systat Software, San
Jose, California, USA).

2.3 Results
Representative data from one individual showing an ECG recording as well as brachial
artery BP and MCA BV waveforms during a sit-to-stand task are presented in Figure 2.1.
This figure displays the selection of data that were utilized for analysis. Figure 2.2
presents the group averaged BP, BV, Ri, and Ci responses to standing. The sit-to-stand
protocol elicited a reduction in mean BP of 20 ± 9 mmHg. One male participant exhibited
BP responses (∆SBP = -56mmHg, ∆DBP = -31 mmHg) that meet the criteria for initial
orthostatic hypotension (28). BP began to fall 3 ± 2 beats after standing (3 ± 2 seconds)
and nadir BP occurred at beat 14 ± 2 (11 ± 1 seconds). With standing, Ri was decreased
0.2 ± 0.1 mmHg•cm-1•s-1, with reductions initiated 11 ± 3 beats (9 ± 2 seconds) post
stand. In contrast to the delayed decrease in Ri, Ci began to increase within 2 ± 2 beats (2
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± 1 seconds) from the onset of standing (P < 0.001, d = 3.7 from moment of Ri decrease).
Ci increased 1.16e-3 ± 5.21e-4 cm•s-1•mmHg-1 and peak Ci occurred at beat 15 ± 3 (11 ± 1
seconds). Values of Ci for each beat analyzed during two trials of a sit-to-stand task are
shown in Figure 2.3 for each participant. During seated baseline Ci was 7.87e-4 ± 3.55e-4
cm•s-1•mmHg-1 (range: 3.48e-4 to 1.36e-3 cm•s-1•mmHg-1). Upon standing, Ci increased
by 165 ± 84% from seated baseline (range: 63% to 328%) with peak Ci being 1.95e-3 ±
7.42e-4 cm•s-1•mmHg-1 (range: 7.99e-4 to 2.91e-3 cm•s-1•mmHg-1; P < 0.001, d = 2.4 vs.
seated baseline). After reaching its peak, Ci decreased towards seated baseline values.
PETCO2 was unchanged during standing (39 ± 3 mmHg) compared with seated baseline
(39 ± 3 mmHg; P = 0.94).
Figure 2.4 demonstrates the role of Ci in sustaining systolic BV during standing-induced
reductions in BP from one individual. For the beat corresponding to peak Ci following
the stand (2.4A; Beat 8, Ci = 1.69e-3 cm•s-1•mmHg-1), the value of Ci was manually
adjusted to seated baseline values to mathematically prevent the increase (2.4B; Ci =
5.0e-4 cm•s-1•mmHg-1). The observed result was a decrease in model-predicted systolic
BV. This observation was representative of all participants.
No significant correlation was observed between Ci and corresponding PP (P = 0.40;
Figure 2.5A). In contrast, moderate negative relationships were found between Ci and
corresponding values of SBP (rs = -0.50, P = 0.005; Figure 2.5B) and DBP (rs = -0.49, P
= 0.007; Figure 2.5C). Additionally, no significant correlations were observed between
∆Ci and corresponding ∆PP (P = 0.24), ∆SBP (P = 0.22), or ∆DBP (P = 0.87). A
moderate, positive relationship was observed between seated baseline Ci and peak Ci (r =
0.77, P = 0.02).

82

Pearson’s test of correlation showed a strong relationship between seated baseline Ci
from stand one and stand two (r = 0.95, P < 0.001; Figure 2.6A). Bland-Altman analysis
demonstrated good agreement between baseline Ci from stand one (7.65e-4 ± 3.24e-4
cm•s-1•mmHg-1) and stand two (8.09e-4 ± 3.97e-4 cm•s-1•mmHg-1; mean difference:
4.36e-5 ± 1.40e-4 cm•s-1•mmHg-1, limits of agreement: -2.36e-4, 3.23e-4 cm•s-1•mmHg-1;
Figure 2.6B). Seated baseline Ci did not demonstrate fixed (P = 0.38) or proportional bias
(b: 0.21, P = 0.14) across stands. ICC analysis revealed strong absolute agreement
between baseline Ci from stand one and stand two (ICC = 0.96, P < 0.001, 95% CI:
0.84-0.99).
Additionally, Pearson’s test of correlation showed a strong relationship between ∆Ci
from stand one and stand two (r = 0.90, P = 0.001; Figure 2.6C). Bland-Altman analysis
demonstrated good agreement between ∆Ci from stand one (1.20e-3 ± 5.62e-4
cm•s-1•mmHg-1) and stand two (1.13e-3 ± 5.08e-4 cm•s-1•mmHg-1; mean
difference: -6.94e-5 ± 2.46e-4 cm•s-1•mmHg-1, limits of agreement: -5.61e-4, 4.22e-4
cm•s-1•mmHg-1; Figure 2.6D). Further, ∆Ci did not demonstrate fixed (P = 0.42) or
proportional bias (b: -0.11, P = 0.56) across stands. ICC analysis revealed strong absolute
agreement between ∆Ci from stand one and stand two (ICC = 0.95, P < 0.001, 95% CI:
0.78-0.99).
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Figure 2.1. Representative data from one female participant, aged 19 years, during one
trial of a sit-to-stand protocol. Electrocardiogram (ECG) tracing, brachial artery blood
pressure (BP), and middle cerebral artery blood velocity (BV) are shown. The vertical
solid line represents the time of standing.
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Figure 2.2. Group averaged brachial artery blood pressure (BP), middle cerebral artery
blood velocity (BV), cerebrovascular resistance (Ri), and cerebrovascular compliance
(Ci) responses during sit-to-stand task (n = 9; 6 males, 3 females). Horizontal thick solid
lines represent means and horizontal thin dashed lines represent standard deviations. The
vertical solid line at beat 0 represents the time of standing.
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Figure 2.3. Dynamic changes in cerebrovascular compliance (Ci) for each participant
during two trials of a sit-to-stand protocol (n = 9; 6 males, 3 females). Standing occurs at
beat 0. For each participant, the average percent change in Ci between two stands is
reported.
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Figure 2.4. Representative data from one male participant, aged 24 years, showing the
effect of changing the value of cerebrovascular compliance (Ci) on model-predicted
blood velocity (BV) outcomes. A. Beat corresponding to peak Ci following standing (Ci
= 1.69e-3 cm•s-1•mmHg-1). B. Same beat with Ci manipulated to remain at seated baseline
values (Ci = 5.0e-4 cm•s-1•mmHg-1).
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Figure 2.5. Correlations between hemodynamic variables and cerebrovascular
compliance (Ci). A. Spearman’s rank order correlation (rs) between pulse pressure (PP)
and Ci (P = 0.40). B. Spearman’s rank order correlation (rs) between systolic blood
pressure (SBP) and Ci (P = 0.005). C. Spearman’s rank order correlation (rs) between
diastolic blood pressure (DBP) and Ci (P = 0.007).
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Figure 2.6. Bland-Altman analysis to assess the agreement in seated baseline (BSL)
cerebrovascular compliance (Ci) and the change in (∆) Ci between stand one and stand
two (n = 9; 6 males, 3 females). A. Pearson’s test of correlation for BSL Ci (r = 0.95, P <
0.001). B. Bland-Altman plot of agreement displaying the difference in BSL Ci between
stands as a function of the mean of BSL Ci across stands. Mean difference (solid line)
and confidence limits of the mean difference (± 2SD; dashed lines) are shown. C.
Pearson’s test of correlation for ∆ Ci (r = 0.90; P = 0.001). D. Bland-Altman plot of
agreement displaying the difference in ∆ Ci between stands as a function of the mean of
∆ Ci across stands. Mean difference (solid line) and confidence limits of the mean
difference (± 2SD; dashed lines) are shown.
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2.4 Discussion
The present study provides novel insight into the role of cerebrovascular compliance in
cerebral autoregulatory processes. To our knowledge, this study reports the first
observation of rapid and large but transient increases in Ci with standing-induced
reductions in BP. Of note, the Ci response was distinctly different from the changes in
cerebrovascular resistance which were initiated several seconds later. In contrast to the
delayed reduction in Ri, the change in Ci corresponded temporally to the transient change
in BP. The outcome of the rapid Ci response was a maintenance of systolic BV
throughout the period of decreased BP during the transition from sitting to standing.
Therefore, rapid and transient changes in Ci appear to contribute to the autoregulatory
response to reductions in BP.
Historically, cerebrovascular resistance has been considered as the fundamental
component of cerebral autoregulatory responses. More recently, studies have documented
that application of Windkessel models incorporating both vascular compliance and
resistance, account for greater variation in MCA velocity during dynamic alterations in
BP (9, 26, 27) compared to resistance (9) or BP alone (26), suggesting a quantifiable role
of vascular compliance in autoregulatory control. However, these studies did not account
for actions of drugs on vascular responses (9) and used low pass filtered data (9, 26, 27)
which may have removed rapid compliance patterns. Nonetheless, the present results
support and expand upon these previous findings, providing evidence of large, rapid
increases in Ci that occur during transient reductions in BP. Furthermore, an important
observation of the current study was that transient increases in Ci can precede reductions
in Ri by about 7 seconds during the hypotensive phase evoked by standing.
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The finding of diverging Ci and Ri patterns to standing-induced BP reductions suggest
that vascular compliance and resistance represent distinct processes of vasomotor control.
While this represents the first observation in the cerebral vascular bed, previous findings
in the peripheral vasculature support this notion. For example, sympathoexcitation
induced by lower body negative pressure (24), cold pressor test (7, 24), or mental stress
(7) reduced brachial or radial arterial compliance while sympathoinhibition through
brachial plexus blockade (15) increased radial arterial compliance; in all cases
compliance changed independently of arterial diastolic diameter (i.e., resistance).
Therefore, vascular compliance and resistance represent distinct but complementary
means of regulating flow in the cerebral circulation.
The impact of such rapid and large changes in Ci can be observed in the preservation of
systolic BV throughout the transient hypotensive period. Specifically, while mean and
diastolic BV are decreased upon standing, systolic BV was maintained to seated baseline
levels. This BV pattern is consistent with data that vascular compliance predominantly
affects systolic flow (13, 33) while vascular resistance strongly influences mean and
diastolic flow (31, 33). Based on these data, in the absence of augmented Ci with
standing, systolic BV would decrease in addition to diastolic BV, leading theoretically to
a larger drop in mean BV and therefore total cerebral blood flow. Indeed, when Ci is
manipulated to remain at seated baseline values, a marked reduction in model-predicted
systolic BV is observed in all participants. Consequently, these data broaden our
understanding of dynamic cerebral autoregulation to include contributions from vascular
compliance in the preservation of cerebral blood flow during transient reductions in BP.
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The mechanisms mediating rapid augmentation of Ci with standing are likely complex
and remain speculative. The viscoelastic properties of blood vessels produce a curvilinear
relationship between pressure and volume where greater compliance is expressed at
lower levels of BP (16). Thus, reductions in BP during standing and subsequent
relocation along the pressure-volume curve may have provided passive momentary
enhancements to within-beat Ci. Further, reductions in intravascular BP would affect the
transmural pressure gradient across cerebral vessels that forms the basis of myogenic
reactivity. Bank and colleagues (1995) reported an inverse relationship between
transmural pressure and brachial artery compliance (5). In fact, myogenic responses
elicited by arm elevation produced an increase in brachial artery compliance (13, 31)
while resistance remained unchanged (31). Therefore, augmentation of Ci in the present
investigation may be attributed to active myogenic-mediated reductions in vascular
contractile state.
Reductions in extravascular pressure upon standing are also expected, contributing
passively by increasing the vessel’s ability to express its inherent compliance (17, 32).
Recently, an investigation from our laboratory proposed intracranial pressure (ICP),
arising from cerebral venous blood volume, cerebrospinal fluid (CSF), and the brain
tissue, influences the operating point of Ci in the supine position (32). Reductions in ICP
on moving from supine to sitting postures (18, 23) have been observed, due to hydrostatic
reductions in cerebral venous volume (2) and translocation of CSF from the brain to the
spinal canal (20). Corresponding changes in ICP from the seated to standing postures,
when head elevation above the heart remains constant, are not clear but previous data
suggest further reductions are expected (18, 22). However, we expect ICP to remain
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reduced during standing which contrasts with the transient nature of the Ci response
which returned to baseline levels despite maintenance of the standing position. As such,
the impact of ICP on Ci remains to be resolved.
Importantly, strong within-individual reliability was demonstrated in the current study for
seated baseline Ci and the increase in Ci with standing. However, marked inter-individual
variability was observed in Ci responses to standing. Nonetheless, a large and rapid
increase in Ci was observed in all participants. Therefore, we speculate that augmented
Ci with standing-induced BP reductions represents a fundamental response of the
cerebral vasculature that may become modified by factors including ageing or disease.
Additionally, a major predictor of peak Ci was seated baseline Ci. Therefore, variations
in baseline Ci between participants may arise from differences in inherent elasticity of the
cerebral vasculature, hormonal variations across the menstrual cycle, cardiorespiratory
fitness (14), and baseline hemodynamic parameters (e.g., BP, ICP).
There are methodological limitations that should be considered for the present study.
First, measures of MCA cross-sectional area were not obtained and BV, rather than flow,
calculated an index of cerebrovascular compliance (i.e., Ci). Based on magnetic
resonance imaging methods, our determinations are that over one minute of hypercapnic
stimuli are needed to observe measurable changes in MCA cross-sectional area (11).
Additional studies with higher temporal resolution are needed to establish the impact of
decreased BP on MCA changes within the first minute. Nonetheless, myogenic dilation
of the MCA would be expected to produce a reduction in BV if total flow stayed the
same. Yet, systolic BV remained constant despite the reduced BP. Therefore, additional
mechanisms must be considered. The values of Ci reported in the present study are
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anticipated to scale to inherent compliance of the cerebral vasculature. Second, the
present investigation employed a lumped parameter model for computation of Ci which
substitutes the complex structure of an arterial vascular bed (i.e., branching structure)
with a single tube that encompasses properties representing the bed as a whole (29). With
this approach, we are unable to determine if changes in Ci observed with standing are
uniform across the entire cerebral vascular bed or if differential responses exist at various
levels of the bed (i.e., pial arteries vs. parenchymal arterioles). Third, due to access
difficulties, peripheral measures of BP were used to represent MCA BP waveforms.
Unfortunately, we do not know if, or how, BP waveforms change between the brachial
artery and the MCA although differences in the structure of the vessel (i.e., elastin,
collagen content) (25), as well as ICP may exert some impact. Nevertheless, the
Windkessel model obtained good agreement between the model-predicted and measured
BV waveforms, suggesting any differences in the shape of the BP waveforms between
the two sites would have little impact on model results. Finally, a transient reduction in
BP was employed as a stimulus in the present investigation. Given the presence of
hysteresis in the cerebral circulation (8) it remains unknown whether changes in Ci also
contribute to cerebrovascular responses to transient increases in BP.

2.4.1

Conclusion

This study expands our knowledge of cerebral autoregulatory processes. While previous
investigations suggested that cerebrovascular compliance contributes to the dynamic
regulation of cerebral blood flow (9, 26, 27, 34), this study demonstrates rapid and large
increases in Ci accompanying large reductions in BP elicited with a sit-to-stand
technique. More importantly, the increase in Ci preceded reductions in Ri that are
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typically examined in the context of cerebral autoregulation. Despite delayed alterations
in Ri, systolic BV remained elevated throughout the hypotensive period with standing.
Consequently, the increase in Ci contributes to the preservation of systolic BV and
therefore total cerebral blood flow prior to the onset of the quantifiable vasodilation. On
the basis of these observations, it appears that cerebrovascular compliance provides a
rapid but transient contribution to cerebral autoregulation in addition to alterations in
cerebrovascular resistance.
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Chapter 3

3

Vasodilation by carbon dioxide and sodium nitroglycerin
reduces compliance of the cerebral arteries in humans

Published in Experimental Physiology 106(8): 1679-1688, 2021.

3.1 Introduction
Maintenance of cerebral perfusion and protection against cerebral ischemia relies on
precise, integrative control of the cerebral vasculature. Cerebral vasodilation represents a
critical process for ensuring adequate oxygen supply and the cerebral vessels are sensitive
to a wide variety of dilatory stimuli including arterial carbon dioxide concentrations (2,
13, 14, 34) and nitric oxide (18, 30).
Recently, vascular compliance has emerged as an important contributor to
cerebrovascular regulation and brain perfusion (12, 27). While vascular resistance affects
only the steady component of blood flow, vascular compliance affects the extent of the
blood pressure rise in systole (dampening effect) and the recoil of the vessel wall in
diastole and, as such, represents an important determinant of the oscillatory component of
blood flow (39).
Vasodilation mediates changes in vascular resistance; however, we do not fully
understand whether vasodilation, in the process of altering vascular resistance, also
affects vascular compliance, particularly in the cerebral vascular bed. In the peripheral
vascular bed, vasodilation induced by nitroglycerin produced increases in brachial arterial
compliance at a constant pressure (5). However, an investigation by Carrera and
colleagues (2011) employing hypercapnia-induced vasodilation of cerebral arteries

100

challenged these earlier findings. Using a modeling approach, cerebral arterial blood
volume was predicted from the transcranial Doppler waveforms and cerebral arterial
compliance was calculated as the ratio of the amplitude of blood volume to the amplitude
of blood pressure (11). Hypercapnia imposed a 9% reduction (P = 0.06) in cerebral
arterial compliance from normocapnic conditions, pointing towards a potential effect of
vasodilation on compliance of the cerebral vessels (11). However, to calculate cerebral
arterial blood volume, it was assumed based on earlier reports, that the middle cerebral
artery (MCA) diameter remained constant during the hypercapnic stimulus (11). With
advancement in imaging techniques, more recent findings have demonstrated increases in
MCA diameter with hypercapnia (2, 13, 14, 34). Therefore, changes in cerebral arterial
compliance may have been underestimated in the earlier study by Carrera and colleagues
(2011). Additionally, to our knowledge, no studies to date have explored the impact of
changes in large cerebral artery dilation alone, versus the entire vascular bed including
the downstream segments. The large cerebral arteries provide significant contribution to
the global control of cerebral perfusion (36). Therefore, with approaches such as sodium
nitroglycerin (SNG) and hypercapnia, further insight can be gained regarding the role of
dilating only the larger cerebral artery segment (SNG) (7, 35, 41) or the entire cerebral
vascular bed (hypercapnia).
Based on the data of Carrera and colleagues (2011) and the shift to a greater contribution
of collagen in vessel wall load-bearing potential induced by vasodilation (9), this research
tested the hypothesis that vasodilatory stimuli would decrease compliance of the MCA
vascular bed (i.e., the MCA and the vascular bed downstream from the MCA). To
address this hypothesis, we used a Windkessel modelling approach to calculate
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cerebrovascular compliance before and following the administration of two cerebral
vasodilatory stimuli that operate primarily through endothelial pathways (hypercapnia)
(6, 16, 24) and non-endothelial pathways (sublingual SNG).

3.2 Methods
3.2.1

Ethical Approval

The study was approved by the Health Sciences Research Ethics Board at the University
of Western Ontario (No. 107620) and performed to the standards of the Declaration of
Helsinki except for registration in a database. Participants received written and verbal
explanations of study procedures prior to providing written, informed consent.

3.2.2

Participants

Fifteen young, healthy adults participated in the current investigation (26 ± 5 years, 173 ±
7 cm, 72 ± 16 kg, 7 females). Participants were normotensive and not taking any
medication known to affect autonomic or vascular function. Two participants were on
medication for seasonal allergies (n = 1, Nasonex) and asthma (n = 1, Symbicort).
Menstrual cycle was not controlled for in the present study. Three females were tested
during the early follicular phase (days 5-7), two females in the late follicular phase (days
11-13), one female in the early luteal phase (day 15), and one female in the mid luteal
phase (day 21). Two females were taking oral contraceptives (Alesse levonorgestrel and
ethinyl estradiol).

3.2.3

Experimental Protocol

Participants fasted for four hours, abstained from caffeine and alcohol for 12 hours, and
did not participate in vigorous exercise for 12 hours prior to testing. Body height and
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mass were recorded, and participants assumed a supine position for instrumentation and
testing. Participants were instrumented with an electrocardiogram (ADInstruments Bio
Amp FE132, Colorado Springs, CO, USA) for a lead II tracing and measures of heart rate
(HR). Finger arterial blood pressure (BP) was recorded with a finger
photoplethysmograph on the left hand (Finometer, Finapres Medical Systems, Enschede,
The Netherlands) and brachial artery BP waveforms were reconstructed from the finger
photoplethysmograph signal (8). Participants were instrumented with a headband device
and a 2 MHz pulsed wave Doppler probe (Neurovision TOC2M, Multigon Industries,
Elmsford, CA, USA) was fixed to the headband for insonation of the right MCA. Peak
MCA blood velocity (MCAv) waveforms were recorded. Participants were fitted with a
face mask (Hans Rudolph 7400 Series, Shawnee, KS, USA) and end tidal carbon dioxide
partial pressure (PETCO2) was measured (ML206 Respiratory Gas Analyzer,
ADInstruments, Colorado Springs, CO, USA). Breathing frequency was recorded with a
respiratory strain gauge (1132 Pneumotrace II, UFI, Morro Bay, CA, USA). After resting
in the supine position for at least 10 minutes during instrumentation, three manual BP
measurements were recorded to confirm brachial BP provided by the Finometer.
Data were collected during a SNG protocol and a hypercapnia protocol. The SNG
protocol consisted of a 2-minute baseline period followed by a single sublingual spray of
0.4 mg SNG (Nitrolingual Pumpspray, Sanofi, Laval, QC, Canada). Data collection
continued for 10 minutes following SNG administration. Sublingual SNG has a half-life
of approximately 2-4 minutes (3, 21, 28). After completion of the SNG protocol,
participants rested for at least five minutes before the hypercapnia protocol was initiated
(22 ± 5 minutes following SNG administration). The SNG protocol was always
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completed before the hypercapnia protocol. The hypercapnia protocol consisted of a
2-minute baseline period, followed by breathing a low percentage carbon dioxide (CO2)
gas mixture (5% CO2, balanced oxygen or 6% CO2, 21% oxygen, balanced nitrogen) to
achieve PETCO2 levels at least +5 mmHg from baseline for four minutes. After four
minutes, participants returned to breathing room air for three minutes of recovery. Data
were sampled at 1,000 Hz with a data acquisition system (LabChart 8, PowerLab,
ADInstruments, Colorado Springs, CO, USA) and stored for offline analysis.

3.2.4

Data Analysis

Individual BP and corresponding MCAv waveforms were time-aligned, extracted and
input into a four-element lumped parameter modified Windkessel model for calculation
of a cerebrovascular compliance index (Ci) as described in detail previously (27, 40).
Briefly, resistance (calculated as quotient of mean BP and MCAv) along with initial
values of compliance, viscoelasticity, and inertia are prescribed and applied to the
individual BP harmonics to predict corresponding flow velocity harmonics. The flow
velocity harmonics are reconstructed to complex waveforms which are then compared to
the measured flow velocity waveforms and the level of agreement is quantified as an
error value. The values for compliance, viscoelasticity, and inertia are altered in an
iterative manner to decrease the error between the model-predicted and measured flow
velocity waveforms until a maximal accuracy is reached. At this point the values for
compliance, viscoelasticity, and inertia are deemed representative of the properties of the
vascular bed.
Across a sequence of 10 cardiac cycles, five individual cardiac cycles were selected in an
alternating pattern during each protocol’s baseline period. Following the same pattern,
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five cardiac cycles were extracted at each minute of the SNG protocol (i.e., minute 1
through minute 10) and hypercapnia protocol (i.e., minute 1 through minute 4), and in the
last minute of recovery following hypercapnia. For each cardiac cycle input into the
model, an index of cerebrovascular resistance (CVRi; quotient of mean BP and mean
MCAv) was calculated. Additionally, HR and PETCO2 were analyzed for the cardiac
cycles extracted. For each measure, an average of the five cardiac cycles was calculated.

3.2.5

Statistical Analysis

A one-way repeated measures ANOVA with a Dunnett’s test for multiple comparisons
assessed the impact of time on Ci, CVRi, BP, MCAv, HR, and PETCO2 during SNG and
hypercapnia. The relationship between the change in BP and the change in Ci was
assessed with a Pearson correlation for the hypercapnia protocol. Studentized t-tests
evaluated sex differences in baseline Ci, CVRi, BP, MCAv, and PETCO2 as well as the
change in these variables during SNG administration and hypercapnia. Statistical
analyses were performed using GraphPad Prism 8 (GraphPad Software, LLC, San Diego,
CA) and statistical significance was set as P £ 0.050. Effect sizes were calculated using
G*Power 3.0.10 (17). Data are presented as mean and standard deviation.

3.3 Results
SNG Protocol
Figure 3.1A displays representative BP and MCAv from one female participant during
the SNG protocol. As presented in Figure 3.2A, CVRi was increased following SNG
administration (P < 0.001). From baseline (1.5 ± 0.4 mmHg•cm-1•s-1), CVRi increased by
minute two (P = 0.008, d = 2.5), and reached its maximum at minute 10 after SNG
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administration (2.0 ± 0.6 mmHg•cm-1•s-1; P = 0.002, d = 1.6). In contrast, compared to
baseline (87 ± 8 mmHg), mean BP remained unchanged throughout the SNG protocol (P
= 0.32; Figure 3.2B). Finally, SNG administration led to a decrease in MCAv but neither
HR nor PETCO2 were affected (Table 3.1). Table 3.2 displays baseline BP, MCAv, and
CVRi, as well as the change in these variables by sex.
Overall, Ci was reduced 24 ± 17 % with SNG administration (P < 0.001; Figure 3.3).
Compared to baseline (5.0e-4 ± 2.3e-4 cm•s-1•mmHg-1) Ci was reduced by minute six
following SNG (P = 0.03, d = 1.0) with a nadir reached 10 minutes post SNG
administration (3.6e-4 ± 1.2e-4 cm•s-1•mmHg-1; P = 0.009, d = 1.0). Sex did not impact
baseline Ci or the change in Ci during SNG administration (Table 3.2).
Hypercapnia Protocol
Figure 3.1B displays representative BP and MCAv from one female participant during
the hypercapnia protocol. With hypercapnia, CVRi decreased (P < 0.001; Figure 3.4A).
Compared with baseline (1.8 ± 0.4 mmHg•cm-1•s-1) CVRi was reduced by the first
minute of hypercapnia (P = 0.03, d = 0.8) and reached 1.4 ± 0.4 mmHg•cm-1•s-1 after four
minutes (P = 0.001, d = 1.3). The CVRi value following three minutes of recovery (1.9 ±
0.4 mmHg•cm-1•s-1) returned to the pre-protocol baseline (P = 0.13). In contrast, mean
BP increased with hypercapnia (P < 0.001; Figure 3.4B). Compared with baseline (86 ±
10 mmHg), mean BP increased by the first minute of hypercapnia (P = 0.002, d = 0.9)
and reached 91 ± 10 mmHg after four minutes of hypercapnia (P < 0.001, d = 1.3).
Following three minutes of recovery, mean BP returned to baseline (87 ± 10 mmHg, P =
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0.43 vs BSL). Despite an increase in mean BP with hypercapnia, there was not a
significant relationship between the change in mean BP and the change in Ci (r = -0.08, P
= 0.79). Further, hypercapnia did not impact pulse pressure (P = 0.37). During
hypercapnia, PETCO2 and MCAv increased as expected and HR was unaffected (Table
3.1). Female participants demonstrated larger increases in BP and MCAv despite similar
changes in PETCO2 (Table 3.2).
Figure 3.5 presents reductions in Ci during the hypercapnia protocol (P < 0.001). At
baseline, Ci was 4.4e-4 ± 1.9e-4 cm•s-1•mmHg-1. By the first minute of breathing CO2, Ci
declined from baseline (P = 0.001, d = 1.2) and was decreased by 28 ± 9 % at minute four
of the protocol (3.1e-4 ± 1.4e-4 cm•s-1•mmHg-1; P < 0.001, d = 1.7). Following three
minutes of recovery, Ci returned to baseline and was 4.2e-4 ± 1.5e-4 cm•s-1•mmHg-1 (P =
0.95). Baseline Ci as well as the change in Ci during hypercapnia did not differ by sex
(Table 3.2). The change in Ci during hypercapnia did not differ between participants who
were exposed to the 5% and 6% CO2 gas mixtures (P = 0.21).
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Table 3.1. End tidal carbon dioxide partial pressures and hemodynamic variables during
sodium nitroglycerin and hypercapnia.
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Table 3.2. End tidal carbon dioxide partial pressures, hemodynamic, and cerebrovascular
variables during sodium nitroglycerin and hypercapnia by sex.
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Figure 3.1 Representative blood pressure (BP) and middle cerebral artery blood velocity
(MCAv) data from one female participant during sodium nitroglycerin (SNG)
administration (A) and hypercapnia (B).
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Figure 3.2. Cerebrovascular resistance (CVRi; A) and mean blood pressure (BP; B)
during sodium nitroglycerin (SNG) administration. Mean (squares) and standard
deviation as well as individual data (solid and dashed lines) are presented (n = 15). A
one-way repeated measures ANOVA with a Dunnett’s test for multiple comparisons
assessed differences between each time point and baseline (BSL). * indicates P < 0.050
compared to BSL. SNG administration increased CVRi during minutes 2 through 10
while BP was unchanged.
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Figure 3.3. Cerebrovascular compliance (Ci) during sodium nitroglycerin (SNG)
administration. Mean (squares) and standard deviation as well as individual data (solid
and dashed lines) are presented (n = 15). A one-way repeated measures ANOVA with a
Dunnett’s test for multiple comparisons assessed differences between each time point and
baseline (BSL). * indicates P < 0.050 compared to BSL. Ci was reduced during minutes
6 through 10 following SNG.
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Figure 3.4. Cerebrovascular resistance (CVRi; A) and mean blood pressure (BP; B)
during hypercapnia to +10mmHg. Mean (squares) and standard deviation as well as
individual data (solid and dashed lines) are presented (n = 15). A one-way repeated
measures ANOVA with a Dunnett’s test for multiple comparisons assessed differences
between each time point and baseline (BSL). * indicates P < 0.050 compared to BSL.
Hypercapnia decreased CVRi during minutes 1 through 4 and BP was increased during
minutes 1 through 4 of hypercapnia. CVRi and BP returned to baseline values following
the three-minute recovery (REC) period.
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Figure 3.5. Cerebrovascular compliance (Ci) during hypercapnia to +10mmHg. Mean
(squares) and standard deviation as well as individual data (solid and dashed lines) are
presented (n = 15). A one-way repeated measures ANOVA with a Dunnett’s test for
multiple comparisons assessed differences between each time point and baseline (BSL). *
indicates P < 0.050 compared to BSL. Ci was reduced during minutes 1 through 4 of
hypercapnia and returned to baseline values following the three-minute recovery (REC)
period.
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3.4 Discussion
The present study exposed new knowledge regarding mechanisms mediating changes in
compliance of the cerebral vasculature. While vasodilation mediates changes to vascular
resistance, our understanding of the mechanisms contributing to vascular compliance,
particularly within the rigid skull, remains poorly understood. The findings from the
present study demonstrate that vasodilatory stimuli, including a nitric oxide donor and
elevated PETCO2, reduced Ci by approximately 26% from baseline in a cohort of young,
healthy adults. Given previous evidence that both stimuli dilate the MCA (2, 13, 14, 30,
34) and that hypercapnia also dilates the distal MCA vascular bed, these findings indicate
that the reductions in Ci were largely accounted for by dilation of the larger cerebral
arteries. Further, these findings highlight differences in the effect of vasodilation on
vascular compliance in the peripheral and cerebral vascular beds.
Elevated PaCO2 represents a robust stimulus specific to the cerebral vasculature (1, 25).
To date, one previous study examined the impact of elevated PETCO2 on cerebral arterial
compliance reporting a 9% reduction from baseline (P = 0.06) during a hypercapnia
protocol elevating PETCO2 by approximately 10mmHg (11). In the current study, a
4-minute hypercapnia protocol that also elevated PETCO2 by 10mmHg, elicited large
(28%) reductions in Ci from baseline. The factors contributing to the large between-study
difference are not clear. However, in the previous work by Carrera and colleagues (2011),
the calculation of compliance relied on the determination of cerebral arterial blood
volume from the MCAv waveforms; in doing so, a constant MCA diameter was assumed
based on the prevailing literature at the time. The current model calculated Ci based on
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the frequency-dependent association between BP and MCAv waveforms and did not
assume a constant MCA diameter.
Nitric oxide represents a dilator derived from endothelial and neuronal sources in the
cerebral vascular bed. In the present study, SNG acted as an exogenous nitric oxide donor
administered sublingually and absorbed rapidly (21). The effect of nitroglycerin on
peripheral vascular compliance has been widely investigated. In humans, administration
of nitroglycerin increased brachial or forearm arterial compliance (4, 5, 32, 37).
However, the influence of nitroglycerin on cerebral vascular bed compliance has not been
studied previously to our knowledge. The current findings demonstrate a 24% reduction
in Ci following SNG administration. The divergent findings between the peripheral and
cerebral vascular beds likely relates to the complex relationship between elastin,
collagen, and smooth muscle cells in determining vessel compliance (9, 29, 33). Bank
and Kaiser (1998) highlight that vasodilation can cause an increase or decrease in
compliance dependent on changes in vessel geometry (i.e., radius) and/or wall stiffness.
Vasodilatory stimuli will relax smooth muscle cells, reducing wall tension and enabling
greater vessel compliance. However, cerebral arteries normally exist in a state of dilation
and with additional dilation, the load-bearing potential of elastin may become exhausted
such that collagen predominates in supporting vessel wall tension creating a less
compliant vessel. Further, when this occurs in the context of a pressurized cranium,
reduced vascular distensibility may be predicted.
We suspect the finding of reduced Ci in the present study relates to the direct
vasodilatory effect of hypercapnia and nitric oxide on the large cerebral arteries at the
base of the brain. Previous studies report that the large arteries forming the circle of
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Willis demonstrate an increase in cross-sectional area during a hypercapnia protocol (2,
13, 14, 34). Specifically, the MCA demonstrates an increase in cross-sectional area after
the first minute of breathing a 6% CO2 gas mixture with the peak response occurring at
three to four minutes (14). The present findings are consistent with this temporal profile
as Ci was decreased after the first minute of hypercapnia and was reduced to its nadir
value at minute four. We note that the change in Ci with hypercapnia cannot be
accounted for by changes in BP. Further, with a single sublingual spray of SNG, Schulz
and colleagues (2018) observed an increase in MCA cross-sectional area. Although the
time course of MCA dilation was not reported in the previous investigation, the current
data are consistent with observations that internal carotid artery peak dilation occurs
approximately seven minutes following sublingual nitroglycerin delivery and the dilation
persisted for 10 minutes (10). The present study demonstrated a decrease in Ci six
minutes following SNG and Ci remained reduced 10 minutes post SNG administration.
Therefore, the changes in Ci observed in the present study are related to the MCA
dilation.
While both vasodilatory protocols have been shown to increase MCA cross-sectional
area, the two stimuli demonstrate regional variations. More precisely, hypercapnia
produces dilation at all levels of the cerebral vascular bed (19). In contrast, SNG appears
to dilate the large cerebral conduit arteries (i.e., large cerebral arteries and pial arteries)
but not the downstream cerebral vasculature (i.e., intra-parenchymal arterioles). This
notion is based on previous reports of nitroglycerin-mediated pial artery dilation in dogs
(20), basilar artery dilation in dogs (22), and MCA dilation in humans (18, 30). Despite
large cerebral artery dilation, observation of i) reduced MCAv (7, 15, 30, 38, 41), ii) no
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change in CBF (15, 30, 35, 38) or regional changes in CBF (7), and iii) increased CVRi
(41) suggest that the dilatory effects of exogenous nitroglycerin are located primarily to
extra-parenchymal conduit arteries including the large cerebral arteries at the base of the
brain and the pial vessels on the brain’s surface. In contrast, downstream intraparenchymal arterioles do not appear to dilate in response to nitroglycerin. This outcome
does not appear to be isolated to the cerebral vasculature as data from lower animals
demonstrate nitroglycerin-induced dilation of larger coronary arteries with no change in
diameter of smaller coronary arterioles (23, 26, 31) and humans demonstrate dilation of
the femoral artery but reduced femoral conductance and femoral blood flow (41). The
present study supports the findings of the earlier cerebrovascular studies demonstrating
reductions in MCAv and increased CVRi following SNG administration. Despite these
differences in dilatory profiles across the vascular bed, both stimuli elicited similar
reductions in Ci of approximately 26%. Therefore, the data suggest that large cerebral
artery dilation may be a primary determinant of overall cerebral vascular bed compliance.
The following methodological considerations should be addressed. First, MCAv
waveforms, rather than flow waveforms, were input to the Windkessel model to calculate
an index of cerebrovascular compliance (i.e., Ci). The model relies on the shape of the
waveforms and the MCAv waveform will be highly representative of true blood flow
waveforms. Second, a lumped parameter Windkessel model was employed in the current
study, substituting the complex structure of an arterial vascular bed with a single tube
incorporating properties that represent the entire vascular bed (39). As such, Ci provided
by the model represents Ci of the entire MCA vascular bed (i.e., the MCA and the
downstream vasculature). This methodological approach prevents us from determining
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whether the attenuation of Ci occurred at a specific level of the vascular bed or if the
changes would be representative of the whole vascular bed. However, given the
predominant impact of SNG on the large cerebral arteries outlined above, it may be
argued that the large cerebral arteries form a dominant determinant of changes in overall
compliance of the cerebral vascular bed. Third, the order of procedures was not
randomized in the present study with the SNG protocol conducted first followed by the
hypercapnia protocol in all participants. However, the hypercapnia baseline was not
started until 22 ± 5 minutes following SNG administration. A previous investigation
demonstrated that HR returned to baseline, and blood nitroglycerin concentration was
nearly undetectable, after 20 minutes following a 0.6 mg dose of SNG (3) that was
greater than the current study (0.4 mg). Despite decreased BP even after 30 minutes in
the previous report (3), BP was unaltered in the present investigation. Additionally, with
the lower dosage in the current study, HR did not change. Therefore, we suspect the
current timeline (~20 minutes) with a lower dose of SNG was a sufficient wash-out
period before the hypercapnia protocol.

3.4.1

Conclusion

In conclusion, tight control over cerebral perfusion critically maintains oxygen delivery
and functional integrity. Vascular resistance and compliance represent key mechanical
properties of the vascular bed that importantly contribute to blood flow regulation. The
present findings demonstrate a reduction in Ci following the administration of a nitric
oxide donor (SNG) and during hypercapnia. Similar reductions in Ci, of approximately
26%, were observed in hypercapnia and endothelial-independent SNG protocols which
were not related to BP changes. Therefore, the attenuation of compliance following large
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cerebral artery dilation may be related to a shift to collagen fibers supporting wall tension
with the pressurized cranium as an additional factor, possibly affecting vascular
distensibility through the transmural pressure gradient.
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Chapter 4

4

Regulatory mechanisms of cerebrovascular compliance
in humans: sympathetic, cholinergic, and myogenic
inputs

In preparation for publication.

4.1 Introduction
A combination of steady-state and pulsatile flow mechanics are involved in the control of
blood flow through a vascular bed (47). The cerebral circulation requires precise
regulation of blood flow to ensure adequate perfusion and oxygen delivery while
defending against microvasculature damage caused by high blood pressure (BP).
Historically, studies investigating cerebral blood flow regulation in humans have focused
on modifications to cerebrovascular resistance which affects the steady component of
flow. However, the role of pulsatile vascular mechanics, particularly vascular
compliance, remain poorly understood. The importance of considering vascular
compliance in cerebrovascular adjustments has been supported through the use of
Windkessel models, incorporating both vascular resistance and compliance, which more
accurately describe cerebral blood velocity responses during BP alterations when
compared to single-resistance models (14) or pressure alone (43).
Previously, cerebral arterial compliance has been calculated using arterial spin labelling
techniques as changes in cerebral arterial blood volume and changes in brachial BP
between systole and diastole (45). Additionally, cerebral blood volume modelled from
transcranial Doppler blood velocity data, and BP from finger photoplethysmography, has
been used to determine cerebral arterial compliance during normo-, hypo-, and
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hyper-capnic conditions (12). However, these measures were made under steady state
conditions. Recently, we used a Windkessel modeling approach to address the impact of
rapid changes in BP on middle cerebral artery vascular bed compliance, illustrating large
and rapid but transient increases in cerebrovascular compliance during standing-induced
reductions in BP (33). These data implicate a role for cerebrovascular compliance in
cerebral autoregulatory responses. However, the mechanisms governing this feature
remain unstudied.
Primary mechanisms contributing to cerebral autoregulatory responses include neural and
myogenic influences. More precisely, these mechanisms influence modifications in
cerebrovascular resistance that accompany alterations in BP (30, 46). However, the role
these mechanisms play in regulating cerebrovascular compliance remains unknown. In
the forearm vascular bed, it has been shown that sympathetic and myogenic inputs alter
vascular compliance (21, 47) with myogenic inputs providing a dominant effect (21).
Therefore, the present study is aimed at neural and myogenic mechanisms that may be
involved in the regulation of cerebrovascular compliance.
Specifically, in the present study we examine the distinct impact that blockade of
a-adrenergic, endothelial muscarinic, and vascular smooth muscle calcium (Ca2+)
channel mechanisms has on cerebrovascular compliance under baseline conditions and
during 0.03 Hz oscillatory lower body negative pressure (OLBNP) to induce BP
fluctuations. On the assumptions that a-adrenergic and vascular smooth muscle Ca2+
channels induce chronic constrictor stimuli, and that endothelial muscarinic receptors
exert a chronic dilatory effect, this research tested the hypotheses that i) sympathetic and
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myogenic blockades would increase cerebrovascular compliance and ii) cholinergic
blockade would reduce cerebrovascular compliance.

4.2 Methods
4.2.1

Ethical Approval

The studies were approved by the Institutional Review Boards of the Hebrew
Rehabilitation Center for Aged and Spaulding Rehabilitation Hospital. The studies
conformed to the standards of the Declaration of Helsinki and participants provided
informed consent.

4.2.2

Participants

The present study involves retrospective analysis of data derived from three experiments
performed separately and reported previously (25, 26, 42). Experiment 1 was performed
in 11 healthy adults aged 21-40 years (4 females). Experiment 2 was performed in 9
healthy adults aged 21-30 years (4 females). Experiment 3 was performed in 16 healthy
adults aged 21-30 years (7 females). Before all experiments, participants were asked to
abstain from caffeine consumption for at least 12 hours, alcohol consumption for at least
24 hours, and physical exercise for at least 24 hours.

4.2.3

Experimental Protocol

As reported previously (25, 26, 42) participants were instrumented with an
electrocardiogram (lead II; Dash 2000, GE Medical Systems, Waukesha, WI) to measure
heart rate (HR), a finger photoplethysmograph (Portapres, Ohmeda, Finapres Medical
Systems, Enschede, The Netherlands) to measure arterial blood pressure (BP),
transcranial Doppler ultrasound (2 MHz probe; MultiDop T2, DWL Elektronische
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Systeme, Singen, Germany) to measure peak blood velocity (BV) in the middle cerebral
artery (MCA), and a nasal cannula to measure end-tidal carbon dioxide partial pressures
(PETCO2; infrared CO2 analyzer, Model 17515, VacuMed, Ventura, CA, USA). A
20-guage catheter was inserted into an antecubital vein for drug infusion.
The protocol involved 5 minutes of supine rest and oscillatory lower body negative
pressure (OLBNP) applied at 0.03Hz under control conditions. Negative pressure was
applied at -30 mmHg (Experiment 2, Experiment 3) or -40 mmHg (Experiment 1) and
10-15 oscillations were completed. Following completion of the control condition, drug
infusion occurred, and the protocol was repeated. Experiment 1: a 0.14 µg/kg bolus
followed by a 0.014 µg/kg/min infusion of phentolamine to block a-adrenergic effects on
the vasculature. Experiment 2: stepwise injections of 0.2 mg glycopyrrolate were given
over 20-30 minutes (target HR above 100 bpm) to block endothelial muscarinic
receptors. Experiment 3: a 3 mg bolus infusion of nicardipine hydrochloride over 8-10
minutes to block L-type calcium channels on the vasculature.

4.2.4

Data Analysis

Analysis was completed on the supine baseline and 0.03Hz OLBNP conditions
(Experiment 1: n = 9, Experiment 2: n = 9, Experiment 3: n = 10). During the supine
baseline, 10 individual BP and corresponding BV waveforms were extracted and input
into a four-element lumped parameter modified Windkessel model (custom software,
described in detail previously) (48). To account for temporal delays between pressure
pulse arrival at the brachial and middle cerebral arteries, the BP waveform was shifted to
match the foot of the corresponding BV waveform prior to extraction. The 10 BP and
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corresponding BV waveforms were extracted in an alternating pattern (i.e., every second
beat). During OLBNP, 30 individual BP and corresponding BV waveforms were
extracted in the alternating pattern providing data that covered approximately two cycles
of OLBNP. For each beat extracted, the model calculated an index of cerebrovascular
compliance (Ci). Additionally, an index of cerebrovascular resistance (CVRi) was
calculated as the quotient of mean BP and mean BV. For each beat extracted and input
into the model, additional hemodynamic measures were analyzed, including HR, systolic
BP (SBP), diastolic BP (DBP), pulse pressure (PP), systolic BV (SBV), and diastolic BV
(DBV). For each measure, averages were calculated across the 10 values at baseline and
30 values during OLBNP. PETCO2 was assessed for the selection of beats analyzed. To
understand the relationship between drug effects and background blood pressure and
vascular effects, correlations were performed between hemodynamic variables and Ci.
Under baseline and OLBNP, the range in Ci was evaluated as the maximum value minus
the minimum value.

4.2.5

Statistical Analysis

A two-way repeated measures ANOVA evaluated the effect of each drug (Control vs.
Drug) and condition (Baseline vs. OLBNP) on all measures. The absolute agreement in
the change in Ci (drug – control) between baseline and OLBNP conditions was evaluated
by the intraclass correlation coefficient (ICC; two-way mixed effects model). The
relationships between Ci and blood pressure (mean BP, PP, SBP, DBP) and CVRi were
assessed by Pearson’s Product-Moment Correlations. Statistical analyses were performed
using SPSS Statistics 25 (SPSS Inc., Chicago, Illinois, USA). Effect sizes were calculated
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with G*Power 3.0.10 (20). Statistical significance was defined as P < 0.05 and data are
presented as mean and standard deviation.

4.3 Results
Experiment 1: Sympathetic Blockade with Phentolamine
Table 4.1 and Figure 4.1 present the impact of phentolamine on Ci. Overall,
phentolamine increased Ci by 99% at baseline (D 3.5e-4 ± 3.6e-4 cm•s-1•mmHg-1; d = 0.8)
and 157% during OLBNP (D 4.7e-4 ± 5.8e-4 cm•s-1•mmHg-1; d = 0.8; Drug: P = 0.02,
Condition: P = 0.88, Drug-by-Condition Interaction: P = 0.43). In both baseline and
OLBNP conditions there was considerable inter-individual variability in the change in Ci
from control to phentolamine. However, the within-participant change in Ci on going
from control to phentolamine was highly repeatable between baseline and OLBNP (ICC
= 0.8, P = 0.03). OLBNP was associated with a greater range in Ci (control: 2.8e-4 ±
8.7e-5 cm•s-1•mmHg-1, phentolamine: 8.0e-4 ± 5.8e-4 cm•s-1•mmHg-1) compared with
baseline conditions (control: 1.6e-4 ± 5.5e-5 cm•s-1•mmHg-1, phentolamine: 2.8e-4 ± 1.5e-4
cm•s-1•mmHg-1; Drug: P = 0.02, Condition: P = 0.01, Drug-by-Condition Interaction: P =
0.06).
Phentolamine did not affect CVRi (Drug: P = 0.92, Condition: P = 0.37, Drug-byCondition Interaction: P = 0.28; Table 4.1 and Figure 4.2) or mean BP (Drug: P = 0.61,
Condition: P = 0.50, Drug-by-Condition Interaction: P = 0.16; Table 4.2 and Figure 4.2).
Additional hemodynamic measures are reported in Table 4.2. Of note, an increase in HR
was observed with phentolamine (Table 4.2). Importantly, phentolamine did not affect
PETCO2 at baseline (control: 5 ± 0.4 %, phentolamine: 5 ± 1 %) or during OLBNP
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(control: 5 ± 0.3 %, phentolamine: 4 ± 0.4 %; Drug: P = 0.18, Condition: P = 0.07,
Drug-by-Condition Interaction: P = 1.0).
The relationship between Ci and hemodynamic variables, including BP and CVRi, are
presented in Table 4.1. Weak to moderate relationships were observed for all variables.
OLBNP strengthened the relationship between Ci and MAP, SBP, DBP, and CVRi while
phentolamine strengthened the relationship between Ci and PP (Table 4.1).
Experiment 2: Cholinergic Blockade with Glycopyrrolate
Table 4.1 and Figure 4.3 illustrates the changes in Ci with glycopyrrolate infusion.
Following glycopyrrolate, Ci increased by 71% at baseline (D 1.4e-4 ± 1.5e-4
cm•s-1•mmHg-1; d = 0.6) and 41% during OLBNP (D 1.1e-4 ± 2.0e-4 cm•s-1•mmHg-1; d =
0.4; Drug: P = 0.05, Condition: P = 0.01, Drug-by-Condition Interaction: P = 0.65).
Greater Ci was observed under baseline conditions compared with OLBNP. Further, the
change in Ci with glycopyrrolate was highly repeatable between baseline and OLBNP
conditions (ICC = 0.8, P = 0.03). OLBNP was associated with a greater range in Ci
(control: 2.0e-4 ± 8.0e-5 cm•s-1•mmHg-1, glycopyrrolate: 3.3e-4 ± 2.5e-4 cm•s-1•mmHg-1)
compared with baseline conditions (control: 1.7e-4 ± 7.9e-5 cm•s-1•mmHg-1,
glycopyrrolate: 2.0e-4 ± 6.8e-5 cm•s-1•mmHg-1; Drug: P = 0.13, Condition: P = 0.02,
Drug-by-Condition Interaction: P = 0.27).
Following glycopyrrolate infusion, CVRi was increased (Drug: P = 0.04, Condition: P =
0.32, Drug-by-Condition Interaction: P = 0.45; Table 4.1 and Figure 4.4). Additionally,
mean BP (Drug: P = 0.02, Condition: P = 0.29, Drug-by-Condition Interaction: P = 0.53;
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Table 4.2 and Figure 4.4) and diastolic BP (Table 4.2) were increased while PP was
decreased (Table 4.2) with glycopyrrolate. A marked increase in HR was also observed
following glycopyrrolate infusion (Table 4.2). Notably, glycopyrrolate did not affect
PETCO2 at baseline (control: 5 ± 1 %, glycopyrrolate: 5 ± 1 %) or during OLBNP
(control: 5 ± 0.5 %, glycopyrrolate: 5 ± 1 %; Drug: P = 0.35, Condition: P = 0.35,
Drug-by-Condition Interaction: P = 0.35).
Weak to moderate relationships were observed between Ci and hemodynamic variables
including BP and CVRi (Table 4.1). OLBNP strengthened the relationship between Ci
and MAP, SBP, PP, and CVRi and glycopyrrolate had no effect on the relationships.
Experiment 3: Myogenic Blockade with Nicardipine
Table 4.1 and Figure 4.5 outline the impact of nicardipine on Ci. Overall, nicardipine
increased Ci by 97% at baseline (D 2.2e-4 ± 2.1e-4 cm•s-1•mmHg-1; d = 1.2) and 104%
during OLBNP (D 2.3e-4 ± 2.8e-4 cm•s-1•mmHg-1; d = 1.0; Drug: P = 0.01, Condition: P
= 0.53, Drug-by-Condition Interaction: P = 0.86). Additionally, despite high interindividual variability, the intra-individual change in Ci with nicardipine was repeatable
between baseline and OLBNP conditions (ICC = 0.9, P = 0.002). OLBNP was associated
with a greater range in Ci (control: 1.9e-4 ± 5.6e-5 cm•s-1•mmHg-1, phentolamine: 3.4e-4 ±
2.5e-4 cm•s-1•mmHg-1) compared with baseline conditions (control: 1.4e-4 ± 5.7e-5
cm•s-1•mmHg-1, phentolamine: 1.7e-4 ± 6.0e-5 cm•s-1•mmHg-1; Drug: P = 0.07, Condition:
P = 0.01, Drug-by-Condition Interaction: P = 0.13).
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Nicardipine infusion increased CVRi (Drug: P = 0.003, Condition: P = 0.05, Drug-byCondition Interaction: P = 0.20; Table 4.1 and Figure 4.6) and greater CVRi was
observed during OLBNP compared to baseline. An increase in mean BP (Drug: P = 0.03,
Condition: P = 0.20, Drug-by-Condition Interaction: P = 0.08; Table 4.2 and Figure 4.6)
and DBP (Drug: P = 0.01, Condition: P = 0.33, Drug-by-Condition Interaction: P = 0.07;
Table 4.2) occurred with nicardipine with a tendency to elevate pressure more during
OLBNP. The impact of nicardipine on additional hemodynamic measures are outlined in
Table 4.2 including a reduction in mean BV and an increase in HR. PETCO2 was not
impacted by nicardipine at baseline (control: 4 ± 1 %, nicardipine: 4 ± 1 %) or during
OLBNP (control: 4 ± 1 %, nicardipine: 4 ± 1 %; Drug: P = 0.59, Condition: P = 0.052,
Drug-by-Condition Interaction: P = 0.08).
Table 4.1 presents the relationship between Ci and hemodynamic variables (BP and
CVRi). Weak to moderate relationships were observed and OLBNP strengthened the
relationship between Ci and MAP, SBP, and DBP while nicardipine had no effect on the
relationships.
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Table 4.1. Cerebrovascular variables and correlations in all three experiments under
control conditions and following drug infusion at baseline and 0.03Hz OLBNP.
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Table 4.2. Hemodynamic variables in all three experiments under control conditions and
following drug infusion at baseline and 0.03Hz OLBNP.
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Figure 4.1. Cerebrovascular compliance (Ci) before (Control) and after phentolamine
infusion (Phentolamine) under baseline and 0.03Hz oscillatory lower body negative
pressure (OLBNP) conditions. Mean and standard deviation (error bars) as well as
individual data (solid lines) are presented.
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Figure 4.2. Cerebrovascular resistance (CVRi) and mean blood pressure (BP) before
(Control) and after phentolamine infusion (Phentolamine) under baseline and 0.03Hz
oscillatory lower body negative pressure (OLBNP) conditions. Mean and standard
deviation (error bars) as well as individual data (solid lines) are presented.
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Figure 4.3. Cerebrovascular compliance (Ci) before (Control) and after glycopyrrolate
infusion (Glycopyrrolate) under baseline and 0.03Hz oscillatory lower body negative
pressure (OLBNP) conditions. Mean and standard deviation (error bars) as well as
individual data (solid lines) are presented.
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Figure 4.4. Cerebrovascular resistance (CVRi) and mean blood pressure (BP) before
(Control) and after glycopyrrolate infusion (Glycopyrrolate) under baseline and 0.03Hz
oscillatory lower body negative pressure (OLBNP) conditions. Mean and standard
deviation (error bars) as well as individual data (solid lines) are presented.
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Figure 4.5. Cerebrovascular compliance (Ci) before (Control) and after nicardipine
infusion (Nicardipine) under baseline and 0.03Hz oscillatory lower body negative
pressure (OLBNP) conditions. Mean and standard deviation (error bars) as well as
individual data (solid lines) are presented.
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Figure 4.6. Cerebrovascular resistance (CVRi) and mean blood pressure (BP) before
(Control) and after nicardipine infusion (Nicardipine) under baseline and 0.03Hz
oscillatory lower body negative pressure (OLBNP) conditions. Mean and standard
deviation (error bars) as well as individual data (solid lines) are presented.
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4.4 Discussion
The present study exposed new fundamental knowledge regarding mechanisms
regulating cerebrovascular compliance in humans. We observed augmented Ci after
blockade of a-adrenergic receptors (phentolamine), endothelial muscarinic receptors
(glycopyrrolate), and L-type Ca2+ channels (nicardipine). The effect of the drug infusions
on Ci occurred under baseline conditions and persisted during OLBNP (-30 or -40
mmHg). Notably, a-adrenergic blockade augmented Ci independently of CVRi or mean
BP whereas endothelial muscarinic and L-type Ca2+ channel blockade augmented Ci
concomitantly with increased CVRi and mean BP. These data suggest that a-adrenergic,
endothelial muscarinic, and L-type Ca2+ channel mechanisms are involved in the control
of cerebrovascular compliance in humans.
Complex mechanisms likely mediated the drug-induced changes to cerebrovascular
compliance observed in the present study. Two fundamental mechanisms can be
discussed as determinants of the present observations which relate to i) the structural
elements within the vascular wall including elastin, collagen, and vascular smooth
muscle, and ii) the transmural pressure gradient (difference between extravascular and
intravascular pressure). While the present study was not designed to investigate the
structural components of the vascular wall, in what follows we discuss how these
elements may contribute to the present observations.
The proportions and arrangement of structural elements of the vascular wall, particularly
elastin, collagen, and smooth muscle cells, affect the elastic behaviour of blood vessels
(11, 40). The load-bearing function of elastin and collagen may change acutely depending
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on distending pressure and vessel diameter (27, 37, 40). Typically, elastin supports elastic
tension at low pressures, producing highly compliant conditions, whereas collagen exerts
proportionately greater support of elastic tension with progressive distension leading to a
curvilinear relationship between pressure and diameter (27, 37, 40). Thus, a highly
dilated arterial segment may express poor elasticity. Of note, this pressure-dependent
distension mechanism works passively to affect vessel compliance (6).
The structural elastin and collagenous components interact with the contractile state of
the vascular smooth muscle cells, affecting vascular compliance in an active way. Unlike
elastin and collagen which exhibit elastic tension dependent on the distending pressure
and vessel diameter, smooth muscle cells, when contracted, provide active tension
regardless of pressure and vessel diameter (11, 40). Active constriction of the smooth
muscle cells would be expected to provide resistance against vessel distension thereby
reducing vascular compliance. Indeed, in humans, reductions in vascular compliance of
peripheral conduit arteries have been observed following sympathoexcitatory manoeuvres
(6, 10, 21, 38, 47). Further, relaxation of peripheral conduit arteries by ganglionic
blockade or denervation approaches produced augmented vascular compliance in humans
(6, 19, 22, 23). However, in contrast to these human studies, analyses of excised vascular
segments in animals indicated that the elastic modulus (i.e., a measure of vascular
stiffness) of the canine aorta and carotid artery was reduced with phenylephrine and
norepinephrine infusion, respectively, when plotted as a function of pressure compared to
strain (7, 17). The discrepancies between the results of these studies may relate to the
following factors: i) whether isometric or isobaric studies were performed (4) ii)
methodological approaches (i.e., in vivo or in vitro) (4) iii) whether changes in wall
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stiffness occur (5) iv) the longitudinal stretch of the vessels (49) v) how distending
pressure interacts with vessel diameter to determine the contribution of elastin and
collagen to wall tension (7). We speculate that the increased vascular compliance
following vasoconstrictor stimuli in the animal studies may have been related to the
dilated baseline state of the aorta and carotid arteries where collagen would bear the
tensile load and vasoconstriction would shorten the luminal circumferential distance,
bringing greater load-bearing potential from elastin into play, increasing elasticity.
In addition to structural factors within the vessel wall, cerebrovascular compliance is also
affected by extravascular pressure. In our modelling studies, the pressurized cranium
effectively restricts the ability of the cerebral vascular bed to express its elasticity (48),
particularly in the supine posture where venous volume and intracranial pressure (ICP)
are elevated compared to upright postures. Thus, reductions in ICP should increase
compliance of the intracranial compartment providing an environment where the cerebral
vessels can express greater compliance (29, 48).
Sympathetic Blockade with Phentolamine
The present finding of increased Ci following phentolamine infusion supports the
hypothesis that adrenergic mechanisms are involved in the regulation of cerebrovascular
compliance. The augmented Ci likely relates to smooth muscle cell contractile state as
phentolamine blocks a-adrenergic receptors on the vasculature leading to smooth muscle
relaxation. This observation aligns with previous reports of increased brachial or radial
vascular compliance following sympathetic ganglionic blockade or denervation in
humans (6, 19, 22, 23).

143

Passive pressure-dependent mechanisms do not explain the increased Ci following
phentolamine. Specifically, augmented Ci occurred independent of changes in mean BP
and PP. In addition, alterations in ICP are not expected in healthy adults following
phentolamine infusion (28). Similarly, alterations in vessel diameter likely did not
contribute to augmented Ci because CVRi was unaltered following phentolamine
infusion. The present results support earlier observations in neonatal piglets where
infusions of phentolamine had little effect on cerebrovascular resistance (1). Nonetheless,
a dose of phentolamine equivalent to the present study did cause reductions in total
peripheral resistance (24) leaving open the question of why similar observations were not
made in the cerebrovascular bed. In our earlier human study, phentolamine reduced
CVRi; however, CVRi was originally elevated by norepinephrine infusion and was
reduced back to baseline but not below (30). Further, the reduction in CVRi in that study
may have been due to a concurrent decrease in BP (i.e., a myogenic effect rather than
sympathetic effect). As such, the independent effect of phentolamine on cerebrovascular
resistance in humans under baseline conditions requires additional research.
Cholinergic Blockade with Glycopyrrolate
The present finding of augmented Ci following glycopyrrolate supports a role for
muscarinic endothelial mechanisms in the regulation of cerebrovascular compliance.
However, the outcome does not support the hypothesis that glycopyrrolate would reduce
Ci. This hypothesis was formed on the basis that glycopyrrolate blocks endothelial
muscarinic receptors leading to a more contracted state of smooth muscle cells and
concurrent reductions in vascular compliance.
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Increased Ci following glycopyrrolate infusion cannot be explained by passive-pressure
mechanisms because this drug increased mean BP and DBP which is consistent with the
effects of the drug to reduce endothelial-mediated vasodilation. Similar findings have
been reported previously (35, 39). The passive effects of increased mean BP would be
expected to reduce cerebrovascular compliance by distending the vascular wall (41) and
transferring elastic wall tension to collagen: yet, Ci increased.
Additionally, CVRi was increased following glycopyrrolate which contrasts with
previous observations of unaltered cerebrovascular conductance at rest (Seifert 2010).
The rise in CVRi with glycopyrrolate indicates that the increased blood pressure and/or
reduction in endothelial dilatory influence, caused moderate vasoconstriction of the MCA
vascular bed. The finding of increased Ci concomitant with increased CVRi, aligns with
previous animal studies of decreased elastic modulus following smooth muscle cell
activation (7, 17). Therefore, we speculate that a relative increase in contractile tension in
the smooth muscle component of the vascular wall contributed to augmented Ci through
a proportional shift in load-bearing from collagen in the dilated state to elastin in the
reduced dilation state.
Glycopyrrolate does not cross the blood-brain barrier (36) and central neurological
cholinergic effects on the vasculature are expected to persist through the current
treatment (18, 39). Further, glycopyrrolate inhibits the action of acetylcholine at
muscarinic receptor subtypes 1 to 5 (M1 to M5) (13); therefore, in addition to endothelial
muscarinic receptors (M3 and M5), glycopyrrolate can affect the action of acetylcholine
on the heart (M2) explaining the large rise in HR. However, glycopyrrolate has a greater
affinity for M1 and M3 receptors (13).
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Myogenic Blockade with Nicardipine
The increase in Ci following nicardipine infusion supports a role for myogenic
mechanisms in the regulation of cerebrovascular compliance. Nicardipine blocks L-type
Ca2+ channels on the vascular smooth muscle cells preventing influx of Ca2+ and the
expected result would be relaxation of smooth muscle cells and subsequently increased
compliance of the vasculature.
Nicardipine infusion increased mean BP and DBP in addition to CVRi. These alterations
were unexpected given the drugs action to relax vascular smooth muscle cells. Indeed, in
hypertensive populations, nicardipine produces reductions in systemic vascular resistance
and BP (2, 31, 44). Additionally, studies investigating the cerebral vascular bed have
demonstrated vasodilation of the cerebral arteries following nicardipine infusion in
patients with cerebral vasospasm (3) or in healthy older men (15). However, studies in
younger, healthy adults have reported increased plasma norepinephrine (8, 34) and
vasoconstriction of the cerebral vascular bed (32) following nicardipine infusion.
Therefore, in this group of young, healthy adults, the mechanism determining the
increased Ci following nicardipine infusion may relate to a smaller vessel diameter
(inferred from increased CVRi) and the dominance of elastin fibers over wall tension.
Methodological Considerations
Some methodological limitations should be considered for the present study. First, all
three drug interventions increased HR which may reduce vascular elasticity (16). Thus,
the impact of a-adrenergic, endothelial muscarinic, and Ca2+ channel blockades on Ci
may be underestimated in the current analysis. Second, measures of vessel cross-sectional
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area were not available in the current study. Therefore, BV waveforms, collected with
transcranial Doppler ultrasound, were used in the Windkessel model in place of blood
flow waveforms resulting in the calculation of a cerebrovascular compliance index (Ci)
rather than a direct measure of compliance. Third, brachial artery BP waveforms were
used in the Windkessel model rather than measures of BP in the MCA. Nonetheless,
modelling approaches suggest that the shape of the BP waveform and absolute pressures
(SBP, DBP, MBP) are comparable between the brachial artery and MCA (9). Notably,
the Windkessel model used in the present study evaluates the harmonics of the
waveforms and not absolute BP or BV. Importantly, despite these limitations, the
Windkessel model is self-validating in that the BV waveform derived by the model is
matched to the measured waveform.

4.4.1

Conclusion

Emerging evidence demonstrates a role for cerebrovascular compliance in dynamic
cerebral autoregulatory processes (14, 33, 43). This study provides novel insight into
neural and myogenic mechanisms that regulate cerebrovascular compliance in humans.
The observation of augmented Ci following a-adrenergic, endothelial muscarinic, and
myogenic blockade broadens our understanding of dynamic cerebral autoregulatory
processes, particularly, the mechanisms contributing to cerebrovascular compliance
responses in humans.
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Chapter 5

5

General Discussion

The three studies that comprise the present dissertation provide new knowledge regarding
the role of cerebrovascular compliance in cerebral autoregulatory processes as well as
mechanisms governing cerebrovascular compliance. Cerebrovascular compliance was
quantified in young, healthy adults under experimental conditions that manipulated
transmural blood pressure, vascular contractile state, and heart rate. First, we illustrate
that in response to transient reductions in blood pressure, rapid, large increases in
cerebrovascular compliance occur in young adults. The increase in compliance
contributes to the preservation of cerebrovascular systolic blood velocity during the
hypotensive phase of standing. Further, we provide novel insight into mechanisms
regulating cerebrovascular compliance including neural, myogenic, and endothelial
influences. We illustrate increases in cerebrovascular compliance following blockade of
sympathetic, cholinergic, and myogenic inputs and reductions in cerebrovascular
compliance following vasodilation by carbon dioxide and sodium nitroglycerin. Taken
together, the studies in the present dissertation demonstrate that cerebrovascular
compliance is modifiable by a variety of mechanisms and importantly contributes to the
regulation of cerebral perfusion.
The study of human cerebrovascular compliance has emerged in the last 15 years with the
application of non-invasive techniques including magnetic resonance imaging, optic
imaging, and modelling approaches. To date, imaging techniques have quantified
cerebrovascular compliance under resting conditions, for example, by evaluating changes
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in cerebral arterial blood volume (by arterial spin labelling) relative to changes in blood
pressure (measured at the brachial artery) (47, 50). To address the role of vascular
compliance in pressure-flow relationships, Windkessel modelling approaches were
applied under conditions of dynamic fluctuations in blood pressure (10, 45, 46). Stronger
fits were observed when the measured middle cerebral artery blood velocity was
compared to the blood velocity profile modelled using a Windkessel model compared
with a single-resistance model (10) or blood pressure alone (45). Therefore, these
investigations provide evidence that vascular compliance represents an important
contributor to cerebral blood velocity responses during transient blood pressure
alterations. Study One from the present dissertation supports these findings while also
extending our knowledge by quantifying the nature of the cerebrovascular compliance
response during transient hypotension. More precisely, cerebrovascular compliance
began to increase within 2 seconds of standing and more than doubled from seated
baseline (156% increase), before returning to baseline levels. Further, our study
illustrated that the vascular compliance response was distinctly different than the vascular
resistance response. This was the first study to address both vascular resistance and
compliance responses to blood pressure alterations in the cerebral vascular bed. A
previous investigation in the forearm vascular bed observed that vascular resistance and
compliance can be altered independently of one another in response to certain stimuli
including arm elevation above the heart (52). Study One of the present dissertation
demonstrates temporally distinct compliance and resistance responses to transient
hypotension whereby alterations in resistance were delayed by approximately 7 seconds
from changes to compliance. Lastly, Study One provided evidence that the rapid and
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large increase in cerebrovascular compliance upon standing preserved cerebrovascular
systolic blood velocity throughout the hypotensive phase. Therefore, vascular compliance
contributes importantly to the regulation of cerebral perfusion during dynamic changes in
blood pressure.
While mechanisms regulating changes in cerebrovascular resistance have been studied
extensively in humans, it remains unknown whether these mechanisms also alter
cerebrovascular compliance. Changes in vessel diameter mediate alterations in vascular
resistance, and vasodilation represents a critical process for maintaining perfusion in the
cerebral vasculature. Investigations of the peripheral vasculature have demonstrated
increases in vascular compliance following vasodilation by nitroglycerin (3, 4, 39, 48).
However, preliminary data from the cerebral vascular bed challenge these findings with
report of a trend towards a 9% reduction (P = 0.06) in vascular compliance with
vasodilation induced by hypercapnia (9). Study Two of the present dissertation supports
the findings by Carrera and colleagues (9) with findings of reduced cerebrovascular
compliance following two vasodilatory stimuli: sodium nitroglycerin, acting through nonendothelial pathways, and hypercapnia, acting primarily through endothelial pathways (5,
15, 25). Both stimuli produced similar reductions in cerebrovascular compliance, of
approximately 26%, from baseline despite demonstrating differing dilatory profiles.
While hypercapnia represents a global dilator producing dilation at all levels of the
cerebral vascular bed (18), sodium nitroglycerin dilates the large conduit arteries but not
the downstream vasculature (23, 30, 38). Taken together, these findings suggest that
dilation of the large cerebral arteries appears to be a primary determinant of overall
compliance of the cerebral vascular bed.
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Neural innervation and mechanical myogenic reactivity represent additional regulators of
vascular resistance. In the forearm vascular bed, sympathetic activation by lower body
negative pressure and a cold pressor test reduced forearm compliance while myogenic
relaxation by arm elevation increased forearm compliance, suggesting that neural and
myogenic inputs regulate peripheral vascular compliance (52). Study Three of the present
dissertation was the first, to our knowledge, to address the impact of these inputs on
human cerebrovascular compliance. Following distinct blockade of 𝛼-adrenergic
receptors (sympathetic blockade), endothelial muscarinic receptors (cholinergic
blockade), and L-type Ca2+ channels (myogenic blockade), increases in cerebrovascular
compliance were observed. In particular, under baseline conditions, cerebrovascular
compliance increased by 99% with phentolamine (sympathetic blockade), 71% with
glycopyrrolate (cholinergic blockade), and 97% with nicardipine (myogenic blockade).
Therefore, Study Two and Three of the present dissertation provide evidence that
numerous mechanisms regulate cerebrovascular compliance including neural inputs
(sympathetic and cholinergic nerves, neuronal nitric oxide), mechanical factors
(myogenic reactivity), and endothelial influences (muscarinic receptors, carbon dioxide,
nitric oxide).
Complex factors likely mediated the observed alterations in cerebrovascular compliance
including distending pressure, intracranial pressure, vascular smooth muscle cells, and
heart rate (see Figure 1.2). In what follows we discuss how these factors may contribute
to the present observations (summarized in Table 5.1).
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Table 5.1. Summary of the changes in cerebrovascular compliance and the factors that
influence vascular compliance.

Distending Blood Pressure
Elastin and collagen differentially contribute to vessel compliance dependent on the
distending pressure (7, 36). Under conditions of low distending pressure, elastin fibers, in
their unstretched length, support wall tension and consequently the vessel demonstrates
greater compliance (7, 36). In contrast, during high pressure conditions, support of wall
tension transitions to collagen fibers as they become stretched, leading to a stiffer vessel
(7, 36). In the present dissertation, changes in arterial blood pressure could explain the
standing-induced increase in compliance (decreased blood pressure; Study One) as well
as the decreased compliance following carbon dioxide (increased blood pressure; Study
Two). However, in both cases there was not a significant relationship between the change
in blood pressure and the change in compliance suggesting other mediators were
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involved. Further, increased blood pressure during glycopyrrolate and nicardipine
infusion would be expected to reduce vascular compliance yet increases in
cerebrovascular compliance were observed. Therefore, in the present dissertation, passive
alterations in distending blood pressure did not appear to contribute greatly to changes in
vascular compliance, at least in the context of present experimental conditions.
Intracranial Pressure
In the cerebral vascular bed, intracranial pressure contributes importantly to the
transmural pressure gradient. In the context of the rigid skull, intracranial pressure
appears to suppress cerebrovascular compliance (19, 53). As such, reductions in
intracranial pressure are expected to increase overall compliance of the intracranial
compartment enabling greater vessel compliance. While measures of intracranial pressure
were not collected in the present studies, based on previous reports, we expect reductions
in intracranial pressure (~5-10 mmHg) with a postural shift from sitting to standing (26,
34). Therefore, intracranial pressure may contribute to increased vascular compliance in
the sit-to-stand model (Study One). Further, intracranial pressure may influence the
compliance of the cerebral vasculature under conditions of vasodilation and increased
cerebral blood flow such as during hypercapnia (Study Two). However, previous
investigations regarding changes in intracranial pressure during hypercapnia have
reported equivocal findings. In healthy adults, a noninvasive modelled estimate of
intracranial pressure was not elevated during hypercapnia (24). In contrast, severely head
injured patients (51) and chronic headache patients (1) undergoing intracranial pressure
monitoring, demonstrated increased intracranial pressure with hypercapnia. Additionally,
a previous investigation in humans demonstrated increased intracranial pressure
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following intravenous administration of nitroglycerin (14). Therefore, intracranial
pressure may contribute to the reduction in cerebrovascular compliance during
hypercapnia and following sodium nitroglycerin administration (Study Two).
Vascular Smooth Muscle Cells
Vascular smooth muscle intricately affects compliance through active alterations in the
tension of the vessel wall and/or vessel diameter (2). Relaxation of vascular smooth
muscle may i) reduce the active tension in the vessel wall without changing vessel
diameter, enabling greater vessel compliance, or ii) elicit vasodilation which, dependent
on the starting vessel diameter and magnitude of dilation, may produce a shift from
elastin to collagen fibers supporting wall tension and reduce vascular compliance (Figure
5.1). In the present dissertation, standing-induced transient hypotension is expected to
elicit a myogenic-mediated relaxation of smooth muscle. As such, initial relaxation of
smooth muscle could play a role in the large and rapid increase in compliance observed,
at least prior to the onset of vessel dilation as indicated by the temporally delayed (~7
seconds) reduction in vascular resistance (Study One). Further, we suspect that blockade
of 𝛼-adrenergic receptors with phentolamine infusion augmented compliance through the
relaxation of smooth muscle but no significant change in vessel diameter as resistance
remained unchanged (Study Three). Therefore, these findings support that smooth muscle
relaxation without vessel dilation increases vascular compliance through a reduction in
active wall tension. In contrast, carbon dioxide and sodium nitroglycerin produce dilation
of the cerebral vasculature (or at least the large cerebral arteries) as demonstrated
previously (12, 37). Because the cerebral vessels are dilated under baseline conditions,
further dilation by sodium nitroglycerin and carbon dioxide would induce a shift from
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elastin to collagen fibers supporting wall tension, thereby reducing vascular compliance
(Study Two).
In contrast to the above scenario of smooth muscle relaxation, activation of smooth
muscle cells could i) increase active tension in the wall thereby resisting vessel distension
(reduced compliance) or ii) produce vessel constriction that would, depending on the
starting vessel diameter and magnitude of constriction, reduce the diameter of the vessel
and return elastin and collagen to their unstretched lengths enabling elastin to support
wall tension (increased compliance; Figure 5.1). Due to the dilated state of cerebral
vessels under resting conditions, we suspect that constriction of the vasculature (inferred
by elevated vascular resistance), would produce a shift from collagen to elastin
supporting wall tension contributing to the increased vascular compliance with
cholinergic blockade by glycopyrrolate and myogenic blockade by nicardipine (Study
Three). Overall, vascular smooth muscle contributes significantly to changes in vascular
compliance in the context of the present studies.

Figure 5.1. Effect of smooth muscle relaxation and activation on vascular compliance
mediated through changes in blood vessel wall stiffness and vessel geometry.
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Heart Rate
Heart rate affects vascular compliance by altering the duration of the cardiac cycle and as
such, the amount of time the vessel has to distend (13, 16, 29). Heart rate does not appear
to contribute significantly to the observed changes in cerebrovascular compliance in the
three studies included in the present dissertation. In particular, increases in heart rate are
expected to reduce vascular compliance (16, 27). Findings of increased heart rate
concomitant with increased vascular compliance in the sit-to-stand model (Study One)
and during sympathetic, cholinergic, and myogenic blockade (Study Three) suggest that
the changes in compliance were not influenced by heart rate or the observed increases in
cerebrovascular compliance were underestimated. In contrast, an increase in heart rate
could contribute to the reduced compliance observed during hypercapnia (Study Two);
however, correlation analysis demonstrated no significant relationship between the
change in heart rate and the change in compliance. Therefore, heart rate does not appear
to play a significant role in the present findings.

5.1 Perspectives
The studies that compose the present dissertation generated new knowledge regarding
cerebrovascular compliance and advance our understanding of the regulation of cerebral
perfusion in humans. Cerebrovascular regulation quantified as changes in cerebrovascular
resistance is studied extensively in humans. In contrast, cerebrovascular compliance has
emerged as a relatively new area of interest. Nonetheless, the present dissertation
highlights the critical role that vascular compliance plays in regulating cerebral blood
flow.
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Investigating alterations to cerebrovascular regulatory processes with age and disease are
critical to our understanding of the development of cerebrovascular diseases, including
stroke and dementia. Stroke and dementia represent major chronic diseases and leading
causes of disability worldwide (17, 44). Indeed, one leading hypothesis of Alzheimer’s
disease considers early vascular dysregulation that precedes neuropathological alterations
(e.g., plaque buildup) and ultimately declines in brain function (20). Previous studies that
have investigated cerebrovascular regulatory processes with ageing have provided
evidence of unaltered dynamic cerebral autoregulation using a variety of approaches (8,
28, 40, 49). Further, studies examining cerebrovascular reactivity to carbon dioxide have
demonstrated no differences between young adults and older adults (11, 33, 41)
especially when reductions in brain volume with ageing are considered (11). However,
these studies focused on cerebrovascular resistance thereby overlooking potential agerelated changes to vascular compliance. In the systemic circulation, central arterial
compliance is reduced with ageing (31, 43) and similar age-related changes are expected
in the cerebral vasculature. Indeed, one previous investigation demonstrated declines in
cerebral arterial compliance with age using optical imaging approaches (42). Therefore,
age-related reductions in cerebrovascular compliance may contribute to the development
of cerebrovascular disease by affecting oscillatory blood flow regulation. Specifically,
reductions in vascular compliance are associated with greater blood pressure and flow
pulsatility which increases the risk of cerebral microvascular damage (21). Cerebral
microvascular damage, in the form of white matter hyperintensities, is associated with the
risk of Alzheimer’s disease and the rate of cognitive decline in Alzheimer’s patients (6).
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Therefore, the series of studies in the present dissertation have generated several key
questions. First, further quantification of cerebrovascular compliance across the adult
lifespan is critical for understanding when age-related reductions in compliance are first
observed as well as the rate of decline with age. Notably, cerebrovascular disease,
including stroke and dementia, disproportionately affects women (17, 22, 35). Therefore,
understanding sex differences in age-related declines in cerebrovascular compliance
represents a critical avenue of research in the field. In particular, understanding the role
of estrogen in cerebrovascular compliance is of interest by examining changes across the
menstrual cycle as well as the impact of menopause. Lastly, an emerging area of research
explores the effect of physical exercise on central arterial compliance (e.g., aorta) with
findings of improved compliance in older adults engaged in physical exercise (32, 43).
Similar studies in the cerebral circulation are pertinent to explore preventative measures
in the development of cerebrovascular disease.

5.2 Conclusion
The present dissertation extends our knowledge of the active role of vascular compliance
in the regulation of cerebral blood flow in humans and generated new understanding of
the mechanisms that affect cerebrovascular compliance. Transient hypotension induced
by standing upright represents a robust physiological stimulus that requires rapid vascular
responses to correct initial deviations in cerebral blood flow. We observed rapid increases
in cerebrovascular compliance that are initiated within 2 seconds of standing. The large
increase in cerebrovascular compliance was initiated prior to reductions in
cerebrovascular resistance which lagged the compliance response by approximately 7
seconds. The large and rapid increase in cerebrovascular compliance contributes to the
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preservation of cerebrovascular systolic blood velocity throughout the hypotensive phase
while the delayed cerebrovascular resistance response corrects mean blood velocity,
returning mean flow to baseline values. Therefore, vascular compliance and resistance
represent distinct yet complimentary vascular responses that contribute to the overall
regulation of cerebral perfusion during transient reductions in blood pressure. The present
dissertation represents the first report of mechanisms governing alterations in human
cerebrovascular compliance. Vasodilation of the cerebral arteries, induced by carbon
dioxide and sodium nitroglycerin administration, produced marked reductions in
cerebrovascular compliance. In contrast, blockade of sympathetic inputs (𝛼-adrenergic
receptors), cholinergic inputs (endothelial muscarinic receptors), and myogenic inputs
(Ca2+ channels) elicited large increases in cerebrovascular compliance. As such, neural,
endothelial, and myogenic mechanisms are involved in the regulation of cerebrovascular
compliance. Therefore, the present dissertation highlights that vascular compliance
represents a critical component of cerebrovascular regulatory processes in humans
contributing to cerebral perfusion. As such, alterations to cerebrovascular compliance
with ageing may lead to cerebrovascular dysregulation and the development of
cerebrovascular disease.
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